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ABSTRAK 
 
Latar Belakang 
 Glaukoma sudut tutup primer merupakan glaukoma yang kedua lazim ditemui di Asia 
dan merupakan punca utama kebutaan disebabkan oleh glaucoma. Di kalangan Asian, 
Glaukoma sudut tutup primer dipercayai progres lebih cepat. Identifikasi pesakit-pesakit yang 
berisiko untuk progress cepat adalah penting untuk mengurangkan morbiditi dan beban 
penyakit. Kebanyakan pengetahuan tentang beban, risiko dan epidermiologi tentang glaukoma 
sudut tutup primer diperolehi dari populasi risiko tinggi, misalnya Cina, Jepun dan India. Di 
Malaysia, majoriti populasi terdiri daripada kaum Melayu dan Cina. Perbezaan antara etnik 
mungkin mempengaruhi tahap progres glaukoma sudut tutup primer. Golongan Melayu telah 
didapati untuk mempunyai penglihatan lebih teruk dan progres pada kadar yang lebih teruk 
kalau berbanding dengan golongan Cina di Malaysia pada masa presentasi penyakit.  
Parameter-parameter biometri segment hadapan mata seperti “axial length” telah diketahui 
mempunyai perkaitan rapat dengan progres glaukoma sudut tutup primer ke tahap yang lebih 
teruk. Dengan ini, kami akan menyiasat parameter-parameter ini di kalangan Melayu dan 
membuat perbandingan antara parameter-parameter ini antara dua etnik major di Malaysia.  
 
Objektif:  
 Untuk membuat perbandingan parameter-parameter biometri segment hadapan mata 
di antara pesakit Melayu dan pesakit Cina glaukoma sudut tutup primer yang progress dengan 
pesakit yang tidak progress. 
 
Kaedah Kajian: 
Ini merupakan satu kajian rentas yang melibatkan 75 pesakit (43 pesakit Melayu glaukoma 
sudut tutup primer dan 32 pesakit Cina glaukoma sudut tutup primer. Pesakit-pesakit ini 
direkruit dari satu pusat glaukoma di Malaysia antara November 2015 hingga Disember 2016. 
Pemeriksaan mata termasuk pengukuran “axial length (AL)” dan “anterior chamber depth 
(ACD)” dengan menggunakan satu alat “non-contact partial coherence inferometer (IOL 
Master, Carl Zeiss, Germany). Manakala, “anterior chamber angle (ACA)” diukur dengan 
“Anterior Segment-OCT (Spectralis Heidelberg, Germany). Keluasan pandangan pada mata 
yang sama dijalankan dengan analisis “Humphrey visual field (HVF) 24-2” untuk mengkaji 
tahap progresi glaukoma pesakit. Pesakit-pesakit dikategorikan kepada dua kumpulan iaitu 
kumpulan yang dengan progresi dan kumpulan yang tanpa progresi. Perbandingan parameter-
parameter biometri segment hadapan mata antara pesakit Melayu dan pesakit Cina glaukoma 
sudut tutup primer yang progres dan tanpa progresi telah dianalisis dengan “independent T 
test” dan “multivariate ANOVA”. 
 
Keputusan: 
Pesakit Cina glaukoma sudut tutup primer mempunyai “AL” yang lebih pendek 
(22.18mm±0.76) dan “ACA” yang lebih sempit (11.09°±1.31) berbanding dengan pesakit 
Melayu. Tetapi, perbandingan di antara “ACD” di antara pesakit glaukoma sudut tutup primer 
Melayu dan Cina didapati tiada perbezaan yang signifikasi. Selepas penyelarasan untuk faktor 
membaurkan, hanya “ACA” didapati ada perbezaan signifikasi. Di kalangan pesakit yang 
progres, semua parameter-parameter (“AL”, “ACD”, “ACA”) didapati mempunyai perbezaan 
ynag signifikasi di antara Melayu dan Cina. Tetapi elepas penyelarasan untuk faktor 
membaurkan, semua parameter tiada perbezaan yang signifikasi.  Walau bagaimanapun, dalam 
kumpulan tanpa progress, tiada perbezaan yang signifikasi dalam parameter-parameter 
biometri segment hadapan didapati di antara dua kumpulan etnik ini. Pesakit Melayu glaukoma 
sudut tutup primer yang progres mempunyai “ACA” yang lebih sempit (11.96°±6.00) 
berbanding dengan pesakit yang tidak progres. “AL” dan “ACD” antara pesakit Melayu 
glaukoma sudut tutup primer yang progres dan tanpa progres tidak berbeza secara signifikan. 
 
Kesimpulan 
 Parameter-paramter biometri segment hadapan mata dipengaruhi oleh faktor eknik  
Kaum Cina mempunyai “ACA” yang lebih sempit berbanding dengan kaum Melayu. Serial 
Pemantauan dengan “Anterior Segment-OCT” adalah penting dalam rawatan glaukoma sudut 
tutup primer. Pemeriksaan parameter-paramter biometri segment hadapan mata adalah penting 
dalam menjangka risiko progress di kalangan kaum Melayu. Penyelidikan yang seterusnya 
diperlukan sebelum kami boleh membuat kesimpulan tentang perkaitan di antara parameter-
parameter biometri sudut hadapan mata dengan progress glaukoma sudut tutup primer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ABSTRACT 
Background: 
Primary angle closure glaucoma (PACG) is the second most common type of glaucoma in Asia, 
and the main cause of glaucoma blindness.  PACG is believed to progress faster among Asians. 
Identification of patients at risk of progression is crucial to reduce the morbidity and disease 
burden. Most knowledge of burden, risk factors and epidemiology about PACG has been 
derived from high risk populations such as Chinese, Japanese and Indians populations. Both 
Malay and Chinese comprise the majority population in Malaysia. Ethnic differences in PACG 
progression may exist; Malays have been found to present with worst visual acuity and 
progression compared to Chinese residing in Malaysia.  Anterior segment biometry parameters 
such as axial length have been associated with progression of PACG. As anterior segment 
biometry has been found to be associated with progression, we aimed to investigate these 
parameters in Malays and to.compare these parameters between the two major ethnicity in 
Malaysia.  
 
Objective: 
The aim of this study were to compare anterior segment biometry parameters in 
progress and non-progress PACG among Malays and Chinese. 
 
Methods:  
This was a cross-sectional study involving 75 patients (43 Malay PACG patients and 32 
Chinese PACG patients) recruited from 1 glaucoma centre in Malaysia recruited between 
November 2015 and December 2016. Ocular examination included axial length (AL) and 
anterior chamber depth (ACD) measurement using a noncontact partial coherence 
interferometer (IOL Master, Carl Zeiss, Germany). Anterior chamber angle (ACA), measured 
by Anterior Segment-OCT (Cirrus, Carl Zeiss, Germany). Humphrey visual field (HVF) 24-2 
analysis of the same eye was done and used to evaluate glaucoma progression. Patients were 
categorized into two groups: those with progression and those without. Comparison of anterior 
segment biometry parameters between Malay and Chinese PACG patients with and without 
progression was analysed using independent T test and multivariate ANOVA analysis. 
 
Results:  
Chinese PACG patients had shorter AL (22.18mm±0.76) and narrower ACA (11.09°±1.31) 
than Malay PACG patients. There was no significant difference between the ACD of Malay 
and Chinese PACG patients. After adjustment for confounding factors., only ACA was 
significantly difference. Among patients with progression, all the anterior segment biometry 
parameters (AL, ACD, ACA) were significantly different between Malays and Chinese. 
However, after controlling for confounding factors, there was no significant difference, In the 
group without progression, no significant differences in anterior segment biometry parameters 
were observed between the two ethnic groups. Malay PACG patients with progression had 
narrower Anterior Chamber Angle (ACA) (11.96°±6.00) compared to non-progressing 
patients. Axial Length (AL) and Anterior Chamber Depth (ACD) did not differ significantly 
between Malay patients with and without progression.  
 
Conclusion:  
There was racial influence in ocular biometry measurement in PACG patients. Chinese has 
significant narrower ACA compared to Malays. Serial AS-OCT monitoring is important in 
management of PACG. Evaluating anterior segment biometry parameters is essential in 
predicting risk of progression in Malay PACG. Further researches and larger studies need to 
be conducted before we can further conclude the association of the anterior segment biometry 
parameters with progression of PACG. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Chapter 1 
Introduction  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1 PRIMARY ANGLE-CLOSURE GLAUCOMA (PACG) 
PACG is the major form of glaucoma in Asia, and late presentation has been shown as the 
major contributory factor for blindness (Chen, 2004). PACG is characterized as a chronic, 
progressive visual field loss and optic nerve cupping, often associated with an elevated 
intraocular pressure (IOP) due to the presence of iridotrabecular contact (ITC) by gonioscopy, 
which can either be appositional or synechial, in the absence of underlying secondary ocular 
disease ("European Glaucoma Society," 2014). The rise in IOP is a result of poor aqueous 
outflow through the trabecular meshwork because of the ITC leading to a build-up in aqueous 
within the eye, hence increased in IOP (Niwas et al., 2016). Typical symptoms of PACG 
especially if they have an Acute primary angle closure (APAC) include eye pain, frontal 
headache on the side of affected eye, nausea and vomiting, “halos” around lights at night, and 
very blurred vision ("European Glaucoma Society," 2014; "Glaucoma Research Foundation," 
2012). However, majority of those with PACG presents as a chronic, asymptomatic form while 
the acute, symptomatic ones are seen in less than 25% of cases (Foster et al., 2002; Quigley, 
2011). 
 
The current classification of PACG is based on clinical observations in European populations 
and can be classified into three types; Primary angle closure suspect (PACS), Primary angle 
closure (PAC) and PACG. PACS is defined as an eye in which 180o or more appositional 
contact between the peripheral iris and posterior trabecular meshwork is considered possible 
with normal IOP, no peripheral anterior synechiae (PAS) and no evidence of glaucomatous 
optic neuropathy (GON). PAC is defined as an eye with 180o or more occludable drainage 
angle and features indication that trabecular obstruction by the peripheral iris has occurred, 
such as raised IOP of more than 21 mmHg, PAS, iris whirling, “glaucomflecken” lens 
opacities, or excessive pigment deposition on the trabecular surface in the absence of GON. 
The term PACG is used to indicate PAC eyes with GON ("European Glaucoma Society," 2014; 
Foster et al., 2002).  
 
PACG has a relatively higher prevalence and tends to be asymptomatic in East Asians (He et 
al., 2006a). Compared to eyes with previous history of symptomatic angle closure, 
asymptomatic PACG was noted to carry poorer visual outcome as they usually present with 
severe to end-stage visual field loss at first presentation to hospital. (Ang et al., 2004b). 
 
 
1.1.1 Prevalence of PACG in Malay & Chinese population 
Glaucoma is the second leading cause of blindness worldwide, following cataract (Quigley, 
1996; Thylefors et al., 1995). WHO has estimated that 4.5 million people are blind due to 
glaucoma (Quigley and Broman, 2006). It also projects that nearly half of the bilateral 
blindness attributable to glaucoma by 2020 will be caused by angle closure glaucoma, in which 
Asians will represent 87% of those with PACG (Quigley and Broman, 2006). In Malaysia, 
glaucoma emerged as the fifth leading cause of both blindness and low vision based on the 
National Eye Survey 1996 (Zainal et al., 2002). This represents to roughly 1.8% of all bilateral 
blindness and 1.8% of all low vision in our country’s population (Zainal et al., 2002). 
 
Asia constitutes for a disproportionately higher prevalence of PACG (Quigley, 1996). Based 
on the prevalence models by Quigley and Broman (2006), in 2010 higher prevalence of PACG 
cases are seen in Asian countries; China 1.26%, Southeast Asia 1.20%, India 0.80%, as 
compared to the lower prevalence seen in other parts of the world; Europe 0.25%, Latin 
America 0.19%, Africa 0.16% (Quigley and Broman, 2006). An exception to Japan and Middle 
East which registered a lower than average prevalence of 0.39% and 0.16% respectively 
(Quigley and Broman, 2006). Therefore, Asians represents 87% of the 15.7 million with ACG 
(Quigley and Broman, 2006). 
 
Ethnic or geographic differences in the prevalence rates of PACG are well known, with 
relatively high prevalence rates (1.1%-2.0%) in Chinese, Mongolian, and Singaporean Chinese 
(Sawaguchi et al., 2012). Studies show that the Chinese population is one of the most at risk 
for developing PACG (Hu, 1989b). It is estimated that 3.5 million people in China have PACG 
and 28 million have narrow anterior chamber angles (Foster and Johnson, 2001).  
 
The Malay race accounts for 5% of the world’s population. Despite there are approximately 
300 million to 400 million people of Malay ethnicity living in Asia ("Population Reference 
Bureau ", 2016), the burden, causes, risk factors and epidemiology of blinding eye diseases in 
this ethnic group are not well studied. 
 
Based on the data released by the Department of Statistics, Malaysia, the population of 
Malaysia was 28,334,135, making it the 42nd most populated country. Malaysia is a 
heterogenous population with many races, of which Chinese and Malays predominate. Based 
on the National Consensus 2010, Malays make up 61.9% of the population followed by 
Chinese (22.5%) and Indians (6.7%) (Department of Statistics, 2010).  
 
The prevalence of PACG in Malays was 0.12% based on the Singapore Malay Eye Study 
(SiMES) that involved 3280 participants aged 40 to 80 years (Shen et al., 2008). Interestingly, 
although PACG is often associated with Chinese ethnicity, in a retrospective study of chronic 
angle closure glaucoma in Malaysia, Taiwan, and Hong Kong found that the progression rate 
of PACG was higher in Malays when compared to Chinese (Sharmini et al., 2009). Another 
publication by Sharmini AT, et al in 2014 on Malay patients with PACG found that Malay 
PACG patients have the risk of progression up to 16-fold (Liza-Sharmini et al., 2014). A 
genome wide association study showed susceptibility loci associated with PACG, suggesting 
that genetic development of the eye in different races may be a contributory factor in the 
pathogenesis of PACG (Vithana et al., 2012). 
 
1.1.2   Risk Factors for Primary Angle Closure Glaucoma 
It is essential to acknowledge the range of factors that affect its progression due to its blinding 
potential. The risk factors can be divided into non-modifiable and modifiable risk factors. 
 
 
Non-Modifiable Risk Factors 
Age 
Advancing age is a known risk factor for developing PACG (Stephen and Drance, 1997). 
Numerous population-based prevalence studies carried out globally supported this. A study 
about prevalence of PACG in a rural southern Indian population showed that the odds for PAC 
and PACG increased with age after adjusting for sex. The odds ratio (OR) increased from 2.34 
(95% CI, 1.14 to 4.79) for the age group of 50 to 59 years to 3.95 (95% CI, 1.81 to 8.61) for 
the subjects aged 70 years or older (Vijaya et al., 2006). In a rural northern China, study found 
the prevalence of PACG for the age group 40 to 49 was 0.63% (95% CI, 0.24 to 1.01) and 
increased to 2.97% (95% CI, 1.72 to 4.23) for those 70 years and above (Song et al., 2011). 
This was seconded by another study on rural and urban northern China population (Wang et 
al., 2010). 
 
In Malaysia alone, it was reported that Malays, for each year increase in age increases the risk 
of disease progression with an odd ratio of 1.02 (95% CI, 0.98 to 1.06) (Liza-Sharmini et al., 
2014). Meanwhile, regional studies in Singapore (Baskaran et al., 2015; Foster et al., 2000c), 
India (Dandona et al., 2000), Europe (Bonomi et al., 2000) and Africa (Buhrmann et al., 2000) 
also supported age as a risk factor for PACG. The incidence of PACG is expected to rise with 
the growth of elderly population in view of accessibility and availability of better health care 
system. 
 
 
Race 
A genome wide association study showed susceptibility loci associated with PACG, suggesting 
that genetic development of the eye in different races may be a contributory factor in the 
pathogenesis of PACG (Vithana et al., 2012). Numerous large population-based studies, the 
disproportionate prevalence of glaucoma among races indicated that race and ethnicity might 
play an important role as a risk factor in PACG. The highest prevalence rates are seen in Inuit 
ranging from 2-4% (Alsbirk, 1973; Arkell et al., 1987; Rens et al., 1988). Relatively high 
prevalence rates (1.1%-2.0%) in Chinese, Mongolian, and Singaporean Chinese (Sawaguchi et 
al., 2012). Studies show that the Chinese population is one of the most at risk for developing 
PACG (Hu, 1989b).  
 
PACG is approximately three times more common in Asians (predominantly Mongolian and 
Chinese population) compared to European-derived populations (He et al., 2006a). Contrary, 
the prevalence reported in the western countries are much lower. For example, in the Blue 
Mountains Eye Study, the prevalence of PACG in Australia was 0.3% (Mitchell et al., 1996); 
in northern Italy with 4,297 study participants, PACG was reported in 0.6% of the patients 
(Bonomi et al., 2000); among Americans in the Beaver Dam Eye Study, the prevalence for 
PACG was 0.04% (Klein et al., 1992). 
 
A meta-analysis of 29 published studies on Asian populations suggested a strong association 
of prevalence with ethnic group through meta-regression analysis (β = 0.27, p = 0.009) (Cheng 
et al., 2014).  
 
Sex 
Gender differences in the prevalence of PACG has been well documented in numerous 
population-based prevalence studies (Lai et al., 2001; Liza-Sharmini et al., 2014; Shen et al., 
2008; Song et al., 2011; Vijaya et al., 2006; Wang et al., 2010).  
 
A meta-analysis of 29 published studies on Asian populations, with data from 84,079 subjects 
with PACG reported prevalence was 0.63% for male and 0.91% for female. A meta-regression 
analysis showed a strong association between a high prevalence rate and a higher proportion 
of female gender (β = 0.41, p = 0.047). The overall female to male ratio of the PACG 
prevalence was 1.51:1 (95% CI, 1.01 to 2.28) (Cheng et al., 2014). 
 
Family history and genetics 
Glaucoma is a complex disease, both clinically and genetically. A positive family history of 
PACG is an additional risk factor. The inheritance of PACG is believed to be polygenic 
(Alsbirk, 1982; Lowe, 1970; Wilensky et al., 1993), although both autosomal dominant and 
recessive inheritance pattern are seen in pedigrees with high a prevalence of PACG. 
 
A study on Chinese population found that the disease prevalence among first-degree relatives 
of PACG patients, only parents account for an odd ratio of 8.76 (95% CI, 2.00 to 38.32) (Kong 
et al., 2011). A high heritability of narrow angles of almost 60% was found. It has also been 
observed that siblings of patients with angle closure have substantially higher risk of angle 
closure as compared to siblings of individual with open angles. The estimated odds of angle 
closure 21.1 times higher (95% CI, 2.8 to 160.1) among siblings of PACS, PAC or PACG 
(Venkatesh et al., 2012). A high heritability of narrow angles of almost 60% was found 
(Amerasinghe et al., 2011). Siblings of Chinese patients with PAC or PACG have almost a 
50% probability of having narrow angles and are more than 7 times more likely to have narrow 
angles than the general population (Amerasinghe et al., 2011). 
 
Visthana EN et al, conducted a genome-wide association study on PACG with 3,771 PACG 
cases and 18,551 controls, and identified 3 strongly associated genetic variants: rs11024102 in 
PLEKHA7; rs3753841 in COL11A1 and rs1015213 located between PCMTD1 and ST18 on 
Chromosome 8q (Vithana et al., 2012). However, these 3 sequence variants only account for 
less than 2 percent of PACG risk (Vithana et al., 2012). A recent study by Nongpiur ME et al, 
identified a common genetic variant within ABCC5 with a significant association with anterior 
chamber depth, which was also associated with a modest risk for PACG (Nongpiur et al., 
2014). 
 
Ocular biometry 
Related studies on biometrical comparisons between normal eyes and eyes with PACG showed 
that PACG eyes are smaller in axial length (AL), have flatter corneas, shallower anterior 
chamber depth (ACD) and thicker lenses (Lowe, 1970; Marchini et al., 1998; Sihota et al., 
2008). Eyes with shorter AL will tend to have thicker lenses sited more forward. Patient with 
PACG was found to have ACD that is 1.0 mm shallow than non-disease eyes, of which, 0.65 
mm of shallowing attributed by the whole lens being anteriorly positioned and 0.35 mm by 
increased in lens thickness (Lowe, 1970).  
 
Obviously, smaller ocular biometry is a risk factor for PACG, but the differences among 
ethnicity in AL and ACD are not substantial enough to explain the increase of angle closure in 
Chinese population. It only means small eyes among the Chinese are more likely to develop 
PACG than small eyes among other ethnicity. Therefore, it is unlikely that a single risk factor 
will fully explain the inter-racial predisposition towards angle closure (He et al., 2006a; 
Quigley et al., 2003). With the widely availability and accessibility to Anterior Segment 
Optical Coherence Tomography (AS-OCT), various studies start to focus anterior segment 
biometry evaluation instead of ocular biometry alone. Nevertheless, the data on the associated 
of anterior segment biometry still very limited. Hence, we will emphasize on anterior segment 
biometry parameters with the association of progression of PACG. Detailed discussion and 
elaboration on the anterior segment biometry parameters will be further discussed. 
 
 
Modifiable Risk Factors 
Intraocular pressure (IOP) 
IOP is the pressure that established when equilibrium between production and outflow of 
aqueous is achieved. “Normal” IOP is defined as 2 standard deviations above or below the 
mean IOP, thus giving a range between 10 to 21 mmHg. IOP that is outside this range is 
considered abnormal (Alimuddin, 1956). IOP has a strong correlation with the progression of 
glaucoma. It is evidenced by a strong correlation between pre-treatment IOP and the extent of 
visual field loss in PACG for both MD and AGIS (Gazzard et al., 2003). Conventionally, IOP 
is considered as a major and only modifiable risk factor in glaucoma progression. Given that 
IOP is the only modifiable risk, many authors have been in search for solutions for controlling 
IOP. It remains a challenging task as IOP itself is affected by various factors including 
environmental factor.  Hence, many hypothesis of modifiable risk factors that strongly 
associate with IOP have been proposed. These includes: physical activity (Williams, 2009), 
cigarette smoking (Chiotoroiu et al., 2013; Jain et al., 2016), body mass index (BMI) (Berdahl 
et al., 2012; Pasquale and Kang, 2009), mean arterial blood pressure (Klein et al., 2005; Werne 
et al., 2008), caffeine (Chandrasekaran et al., 2005; Pasquale and Kang, 2009) and alcohol 
intake (Chiotoroiu et al., 2013; Klein et al., 1993).   
 
 
1.2 PROGRESSION IN PACG 
1.2.1 Definition of progression 
The most common method used to quantify glaucomatous damage is using serial HVF 
evaluation (Brusini and Johnson, 2007). At baseline, it detects and quantifies damage, and in 
subsequent follow-up of a glaucoma patient, it detects stability or progression of the disease 
over a period of time (Susanna Jr and Vessani, 2009). To quantify the severity of glaucomatous 
damage using analysis of structural damage to the ONH and RNFL is still under evaluation 
(Brusini and Johnson, 2007).  
 
Progression of glaucoma can be evaluated either structurally or functionally, or both. In current 
practice, monitoring of disease progression is done using serial evaluation of longitudinal series 
of visual field (functional) measurements (Kirwan et al., 2014; Saunders et al., 2014). It can 
also be used to detect early glaucoma damage (Giangiacomo et al., 2006). Standard automated 
perimetry (SAP) is the most common method for assessing VF in glaucoma and has been 
widely used for many years (Chauhan et al., 2008). It is a recommended measure by The 
European Glaucoma Society for monitoring rate of VF progression in our daily clinical practice 
("European Glaucoma Society," 2014). As in our context, VF progression is the preferred 
method because in view of the reason mentioned above. 
 
Furthermore, the evaluation of visual field progression can be achieved by employing trend 
analysis and event-based analysis (Diaz-Aleman et al., 2009; Spry and Johnson, 2002). 
 
Trend Analysis 
Trend analysis uses mean deviation index (MDI) or visual field index (VFI) calculated from 
the Humphrey visual field (HVF) perimetry, has become a standard index for estimating the 
progression rate of glaucoma (Casas-Llera et al., 2009). Nonetheless, MDI calculation correlate 
poorly with clinical findings (Arnalich-Montiel et al., 2009) because it can be influenced not 
only by increasing glaucoma progression and severity, but also the presence of any media 
opacities such as cataract. Thus, progressive increase in cataract density can falsely be mistaken 
as high glaucoma progression rate (Klein et al., 1996; Koucheki et al., 2004). 
 
The value of MDI will improve after cataract extraction and this may further interfere with the 
evaluation and monitoring of glaucoma progression (Klein et al., 1996; Koucheki et al., 2004). 
Another limitation of using MDI is that it is very weakly centre weighted, therefore it does not 
correlate well to patient’s real visual function (Heijl et al., 1987). 
 
Event-based Analysis 
The event-based analysis is essentially to detect whether progression has occurred or not 
(Caprioli, 2008). Glaucoma progression analysis (GPA) software incorporated in Humphrey 
Visual Field Analyser (HVA) (Carl-Zeiss Meditec, Dublin, CA) is an example of event-based 
analysis (Casas-Llera et al., 2009). The software will give an analysis of pattern standard 
deviation (PSD) values (Casas-Llera et al., 2009) allowing for glaucoma progression 
monitoring. Recently, glaucoma progression index (GPI) was introduced to measure the rate 
of VF progression (Bengtsson and Heijl, 2008). GPI is based largely on PSD analysis but is 
displayed in the form of linear regression (Bengtsson and Heijl, 2008; Casas-Llera et al., 2009). 
It was found that GPI analysis is more accurate than the traditional MDI analysis for 
determining rate of progression and is considerably less affected by cataract or cataract surgery 
(Bengtsson and Heijl, 2008). 
 
The event-based GPA analysis is capable of detecting progression earlier compared to trend 
VFI analysis by 7 months (Casas-Llera et al., 2009). Trend-based analysis requires larger 
number of HVF test to detect progression (Caprioli, 2008). A primary limitation of event-based 
analysis is in detecting progression of defect in the central 10 degrees (Arnalich-Montiel et al., 
2009; Diaz-Aleman et al., 2009). 
 
Various staging systems using SAP have been proposed such as Hodapp-Parrish-Anderson 
(HPA) classification (Hodapp et al., 1993); Glaucoma Staging System (GSS) (Brusini, 1995); 
Advanced Glaucoma Intervention Study (AGIS) (Investigators, 1994) etc. 
We used HPA classification because this is a clinically useful method, and is currently the 
classification system most commonly used in clinical studies (Brusini and Johnson, 2007; 
Hodapp et al., 1993). 
  
Hodapp-Parrish-Anderson (HPA) classification 
HPA classification system considers two criteria: the first criterion is the overall extent of 
damage using both the mean deviation (MD) value and the number of defective points in the 
Humphrey Statpac-2 pattern deviation probability map of the 24-2, SITA-STANDARD test; 
the second is based on the defect(s) proximity to the fixation point (Susanna Jr and Vessani, 
2009). This classification, though popular has its own disadvantages, namely the visual field 
defect is characterized into four relatively course stages and does not give information about 
the location and depth of the defect(s). It may also be impractical in everyday practice because 
it requires time-consuming analysis of every VF test results. Another limitation is this system 
may suggest a significant deterioration when in fact none has occurred (Susanna Jr and Vessani, 
2009) 
According to HPA classification, VF progression is based on: 
1. New defects 
a) 3 or more non-edge points are depressed > 5dB or p < 5% 
b) 1 non-edge points are depressed >10dB 
2. Deeping defects 
a) 3 or more non-edge points are depressed >10dB 
b) May be different if contiguous 
3. Expanding scotoma 
a) 2 points within central 15 degree or 3 points outside central 15 degree are depressed 
>10dB or p>5%. 
 
1.2.2 Factors affecting progression of PACG 
Same as risk factors for PACG, factors affecting progression of can be divided into non-
modifiable and modifiable risk factors.  
Recently emerging research indicates that modifiable risk factors other than  
IOP may be associated with the presence and/or progression of glaucoma (Boland and Quigley, 
2007; Chang et al., 2010; de Voogd et al., 2006; Garg et al., 2014; Werne et al., 2008). A 
systemic review on assessment of risk factors for the progression of glaucoma based on several 
clinical trials, population-based cohort studies and large retrospective studies had been done 
(Friedman et al., 2004). They summarized the risk factors for progression of glaucoma 
includes: 
(i) Age (AGIS; Collaborative Initial Glaucoma Treatment Study, (CIGTS); Early Manifest 
Glaucoma Trial (EMGT)) 
 (ii) Diabetes mellitus (AGIS; CIGTS) 
(iii) Disc haemorrhage (Collaborative Normal Tension Glaucoma Study (CNTGS); EMGT) 
 (iii) female (CNTGS) or male (AGIS)  
(iv) higher IOP at the onset (EMGT) 
(v) higher IOP over the follow up (CNTGS; EMGT)  
(vi) race as in African (CIGTS); Asian (CNTGS)  
(vi) baseline visual field (EMGT).  
Of all the risk factors mentioned above, diabetes mellitus and the IOP were the only modifiable 
risk factors (Friedman et al., 2004).   
There various other hypothesized risk factors includes glaucoma family history (Tielsch et al., 
1991), body mass index (BMI) (Berdahl et al., 2012; Pasquale and Kang, 2009), mean arterial 
blood pressure (Werne et al., 2008), physical activity (Williams, 2009), cigarette smoking 
(Bonovas et al., 2004; Chiotoroiu et al., 2013; Wang et al., 2012), caffeine (Chandrasekaran et 
al., 2005; Pasquale and Kang, 2009) and alcohol intake (Chiotoroiu et al., 2013; Klein et al., 
1993). 
 
1.3 ANTERIOR SEGMENT BIOMETRY PARAMETERS IN PACG PATIENTS 
Various contact and non-contact techniques have been utilized to evaluating the risks of 
progression in PACG. Gonioscopy is the clinical reference standard for evaluating the angle 
and detecting angle closure. Unfortunately, it is subjective and requires considerable skills and 
experience for accuracy. Less invasive methods of assessing the anterior segment including 
ultrasound biomicroscopy (UBM), Scheimpflug Photography (Pentacam) and Anterior 
Segment Optical Coherence Tomography (AS-OCT) have been gaining in popularity, 
especially as they provide quantitative, reproducible data (Reetika S et al). 
 
AS-OCT is a non-contact method that provides cross-sectional, three-dimensional, high-
resolution images using low coherence interferometry to achieve axial resolution in the range 
of 3–20 μm. It allows cross-sectional imaging of anterior segment structures. Apart from this, 
it provides qualitative and quantitative assessment of the anterior segment structures important 
to the pathogenesis and the anatomical variations of glaucoma, and the approach to and success 
of treatment (Reetika S et al).  
 
Optical coherence tomography (OCT) was invented by David Huang and colleagues in 1991. 
Anterior segment imaging using OCT was first demonstrated in 1994 by Izatt et al using light 
with a wavelength of 830 μm. Later, Lubech's group described OCT imaging of laser 
thermokeratoplasty lesions in 1997, and Maldonado and colleagues reported imaging of 
LASIK flaps in 1998. Huang and Izatt in 2001 first demonstrated the modern version of anterior 
segment OCT using 1,310 nm wavelength light and a scan speed of 4000 A-scans/sec, with 
telecentric transverse scanning and rapid scanning optical delay technology in a reference arm 
yielding an axial resolution of 17 μm. Subsequently, the development of spectral domain OCT 
(SD-OCT) came in to place. AS-OCT has been shown to offer precise anterior chamber angle 
(ACA) measurements and to detect more closed angles than gonioscopy (Nolan WP, et al, 
2007).  
 
Biometric studies have demonstrated a few parameters associated with progression of PACG. 
Eyes with acute primary angle closure glaucoma (APACG) have shallower anterior chambers 
(Lowe, 1970; Seah et al., 1997; Wong et al., 2000) and shorter axial lengths (AL) (Foster, 
2002; Lowe, 1970; Seah et al., 1997; Wong et al., 2000) than controls. 
 
1.3.1 Axial length (AL) and PACG 
Axial length (AL) is the distance from the posterior corneal surface to an interference peak 
corresponding to retinal pigment epithelium/Bruch's membrane (Hitzenberger, 1991). AL is 
made up from Anterior Chamber Depth (ACD) + Lens Thickness (LT) + Vitreous Cavity 
Length (VL) (Figure 1) 
   
 
 
Figure 1: Illustration shows the relation of ACD, LT, VL and AL (Adapted from Myopia in 
Asian Subjects with Primary Angle Closure by Kai-Ling Yong et al, 2014) (Yong et al., 2014) 
 
The IOL Master optical biometry system (Carl Zeiss Meditec, AG), and its partial coherence 
interferometry prototypes, have been extensively studied for AL measurement determination 
for the calculation of IOL power. This technology has been shown to have excellent reliability 
and performance accuracy that is, at a minimum, comparable to those of immersion ultrasound 
and significantly better than applanation ultrasound. This is because optical biometry achieves 
accuracy within 20 μm (ultrasound is accurate to 100 μm), thus refractive errors stemming from 
AL mismeasurement are limited to 0.05 diopter (D), which translates to a 5 times more accurate 
measurement than that obtainable by ultrasound (Warren H et al, 2008).   
 
The IOL Master is widely use to aid the accurate calculation and selection of IOL in cataract 
surgery worldwide. The IOL Master measures AL, anterior corneal radii, ACD, and the white-
to-white distance in the human eye. Axial length measurement acquisition failure with the IOL 
Master has been reported in the literature. Causes have been attributed to an inability to position 
the patient at the instrument (eg, head tremor), a combination of low vision and lens opacity, 
and fixation difficulties due to macular disease. Dense nuclear cataracts and posterior 
subcapsular cataracts appear to be the most common reported cause of AL measurement 
acquisition failure. However this had no limitation in our study as those patients were 
coincidentally excluded from our study according to the inclusion and exclusion criteria for 
our study subjects selection. With the proven reliability of IOL Master in obtaining AL, it was 
the chosen technique for AL measurement for our study subjects. 
 
Ocular axial length is strongly associated with the incidence of primary angle closure. 
Biometric studies have shown that acute primary angle closure glaucoma is associated with 
shorter axial length (AL) (Foster, 2002; Lowe, 1970; Seah et al., 1997; Wong et al., 2000). 
Eyes with an axial length of less than 23 mm are at particular risk to develop primary angle 
closure glaucoma (Sherpa D, et al, 2008). In the Bhaktapur Glaucoma Studies, eyes in the 
Nepalese population with occludable angle and angle-closure glaucoma appear to have 
significantly shallower anterior chambers and shorter axial lengths when compared with the 
normal group (Suman ST, et al, 2011). In a cohort of Chinese patients with PACG, a shorter 
axial length (AL) was identified as a risk factor for progressive VF defects in Chinese patients 
under treatment for PACG (Fan et al., 2013). In a 6 years population based study involved 
adults aged 40 years and older from rural and urban South India, shorter AL is a strong predictor 
for progression of PACG (Vijaya L et al, 2016). 
 
1.3.2 Anterior chamber depth and PACG 
ACD is measured along posterior corneal surface to the anterior pole of the lens 
(Hitzenberger, 1991).  
 
 
Figure 2: Illustration demonstrates ACD using IOL Master in the subject 
 
ACD measure by IOL Master demonstrates good reliability and consistency. Hence it was the 
chosen method ACD measurement for our study subjects apart from measuring AL. 
Numerous studies revealed that shallower anterior chamber is one of the contributing factors 
for primary angle closure glaucoma. The association of anterior chamber depth with primary 
angle closure glaucoma is evidenced by a recent study evaluating anterior chamber depth in 
the East Asian population (Devereux JG, et al, 2000; Aung T, et al, 2005). Moreover, according 
to an ocular biometric study published in 2013 (Chen YY, et al, 2013), shallower anterior 
chamber depth predisposes subjects with primary angle closure to progress to primary angle 
closure glaucoma. Lan YW et al 2007 also reported that eyes with PACG and Chronic Angle 
Closure Glaucoma (CACG) with or without Acute Angle Closure (AAC) had shorter AL (Lan 
et al., 2007). 
 
1.3.3 Anterior chamber angle(ACA) and PACG 
The ACA is defined in degrees, in which the angle recess forms the apex and the two sides of  
the angle is formed by drawing the lines through the points defining the angle opening  
distance (AOD 500) (Salim S, 2012).  
 
 
According to Mohammad Pakravan, et al, 2012, individuals with anterior chamber angle ≤26° 
should have prophylactic laser peripheral iridectomy (LPI) as they are at high risk to develop 
primary angle closure attack, with a sensitivity of 77.3% and a specificity of 88.2% 
respectively. However, there is no much data to suggest such an arbitrary cutoff point for LPI. 
 
 1.4 RATIONALE OF STUDY 
 
Risks factors for progression in glaucoma have been mostly obtained from studies on open 
angle glaucoma, and only scanty data available for progression in PACG. Crowded anterior 
segment is a known risk for developing PACG. Wang et al 2002 reported that Chinese eyes are 
anatomically predisposed to PACG. However, among the above-mentioned ocular biometrics, 
axial length is the only ocular biometric parameter consistently associated with progression of 
PACG. ACD was not associated with VF progression in both Quek et al and Fan et al's study 
(Fan et al., 2013; Quek et al., 2011). However, it is still studied in view of its close association 
with PACG. Up to date, there are no reports on the association of ACD with progression of 
PACG, and the association of various anterior segment biometry parameters with progression 
of PACG up to date remains unconfirmed. 
 
The association of anterior segment biometry parameters with progression of PACG is still not 
well researched up to current date. Despite of the high prevalence of PACG in Chinese patients, 
but surprisingly Malay PACG patients tends to progress more rapidly than Chinese patients 
based on a retrospective study by Liza-Sharmini AT, et al (Liza-Sharmini et al., 2014). Hence, 
this study to compare the anterior segment biometry parameters in Malay and Chinese PACG 
patients which will aid in understanding the role of anterior segment biometry parameters with 
progression of PACG. Identification of susceptible patient for progression will help in 
customization of treatment to prevent further glaucomatous damage.   
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Chapter 2 
Objectives  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 GENERAL OBJECTIVE 
To evaluate anterior segment biometry in progress and non-progress PACG among Malay and 
Chinese patients. 
 
 
 
2.2 SPESIFIC OBJECTIVES 
1) To compare the mean anterior segment biometry parameters between Malay and Chinese 
PACG patients 
2) To compare the mean anterior segment biometry parameters with progression between 
Malay and Chinese patients 
3) To compare the mean anterior segment biometry parameters with non-progression between 
Malay and Chinese patients 
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3.2 Abstract 
Objective: To compare anterior segment biometry parameters in progress and non-progress 
primary angle closure glaucoma (PACG) among Malay patients. 
Design: A cross-sectional study. 
Participants: A total of 43 Malay PACG patients who fulfilled inclusion and exclusion criteria 
were recruited from single glaucoma centre in Malaysia. 
Methods: Malay patients with PACG were recruited between November 2015 and December 
2016. Ocular examination was performed including anterior segment biometry measurements 
on selected eye. Axial length (AL) and anterior chamber depth (ACD) was measured using a 
noncontact partial coherence interferometer (IOL Master, Carl Zeiss, Germany). Anterior 
chamber angle (ACA) was measured by anterior segment-OCT (Spectralis Heidelberg, 
Germany). Humphrey visual field (HVF) 24-2 analysis of the same eye was done. Based on 2 
consecutives reliable HVFs, the progression of glaucoma in Malay PACG patients were 
determined according to the Hodapp, Parrish and Anderson’s (HPA) Classification on 
progression was based on HPA analysis; progress and non-progress groups.  
Comparison of anterior segment biometry parameters between progress and non-progress 
Malay PACG patients was analysed using independent t-test and multivariate ANCOVA 
analysis was used to adjust for confounding factors 
Main Outcome Measures: Anterior segment biometry parameters include AL, ACD and 
ACA. 
Results: Malay patients with PACG who developed visual field progression have significant 
narrower ACA (11.96°±6.00) compared to non-progress patients. Neither Axial Length (AL) 
nor Anterior Chamber Depth (ACD) of progress and non-progress Malay PACG patients were 
significantly difference statistically in both groups.  
Conclusions: Evaluating anterior segment biometry parameters is essential in predicting risk 
of progression in Malay PACG. Further researches and larger studies need to be conducted 
before we can further conclude the association of the anterior segment biometry parameters 
with progression in order to provide maximal protection against progression of PACG. 
 
3.3 Introduction  
Primary angle closure glaucoma (PACG) is common in Asian population. The reported 
prevalence ranging between 0.16% and 4.3% in various epidemiological studies conducted in 
Asia countries (Bourne et al., 2003; He et al., 2006; Jacob et al., 1998; Quigley and Broman, 
2006; Ramakrishnan et al., 2003; Thapa et al., 2012; Vijaya et al., 2006). However, primary 
open angle glaucoma (POAG) remains the most common glaucoma in Asia. PACG is believed 
to be responsible for more blindness than POAG (Foster, 2002; Foster and Johnson, 2001; 
George et al., 2010; Quigley and Broman, 2006; Shen et al., 2008).  
 
PACG is believed to progress faster among Asians (Seah et al., 1997). Thicker and highly 
pigmented iris requires higher setting in laser peripheral iridotomy (LPI) in Asian eyes (Aung 
et al., 2004). Highly pigmented iris also contributed to prolong inflammation that may result 
in formation of peripheral anterior synechiae post LPI or acute presentation of angle closure 
(APAC) (Aung et al., 2004). Late presentation is common in Asian population (Liza-Sharmini 
et al., 2014). This is partly due to lack of awareness and accessibility to healthcare (Ang et al., 
2004; Saw et al., 2003).  
 
Majority of PACG is asymptomatic with only 25-35% presented with acute angle closure 
(Liza-Sharmini et al., 2014). APAC may play a protective role to certain extend, due to earlier 
presentation to the tertiary centre (Liza-Sharmini et al., 2014; Wang et al., 2002; Wong et al., 
2000). In previous studies, eyes with shallower anterior chambers (Lowe, 1970; Seah et al., 
1997; Wong et al., 2000) and shorter axial lengths (AL) (Foster et al., 2002; Lowe, 1970; Seah 
et al., 1997; Wong et al., 2000) were associated with PACG. There were evidences to suggest 
that shorter axial length is associated with progression of PACG (Fan et al., 2013). Central 
corneal thickness (CCT) was also found to associate with progression of PACG (Hong et al., 
2007). 
 
However, majority of study on PACG were conducted on Chinese, Japanese and Indian. A 
study on Malay population is scarce. Due to heterogeneity of Asians, understanding PACG in 
Malays is important in strategizing prevention of blindness plan. Furthermore, based on 
retrospective comparative study, Malays were found to present with worst visual acuity and 
progression compared to Chinese residing in Malaysia (Liza-Sharmini et al., 2014). Although 
late presentation and lack of awareness may be the major causative factor but racial influence 
on ocular biometry may also be contributing factor for this complex disease.  
 
The main objective of this study was to compare the anterior segment biometry parameters: 
axial length (AL), anterior chamber depth (ACD) and anterior chamber angle (Sonmez et al.) 
between Malay patients with and without progression of PACG.  
 
 
3.4 Methods 
Patient recruitment 
A cross sectional study was conducted between November 2015 and December 2016 at single 
tertiary centre; Ophthalmology Clinic in Hospital Universiti Sains Malaysia (HUSM), 
Kelantan, Malaysia. This study was received ethical approval from Research and Ethical 
Committee, School of Medical Sciences, Universiti Sains Malaysia (USM/JEPeM/15060236) 
and conducted in accordance to Declaration of Helsinki for human research. 
 
The current classification of PACG is based on clinical observations in European populations 
and can be classified into three types; Primary angle closure suspect (PACS), Primary angle 
closure (PAC) and PACG. PACS is defined as an eye in which 180o or more appositional 
contact between the peripheral iris and posterior trabecular meshwork is considered possible 
with normal IOP, no peripheral anterior synechiae (Pasquale and Kang) and no evidence of 
glaucomatous optic neuropathy (GON). PAC is defined as an eye with 180o or more occludable 
drainage angle and features indication that trabecular obstruction by the peripheral iris has 
occurred, such as raised IOP of more than 21 mmHg, PAS, iris whirling, “glaucomflecken” 
lens opacities, or excessive pigment deposition on the trabecular surface in the absence of 
GON. The term PACG is used to indicate PAC eyes with GON ("European Glaucoma Society," 
2014; Foster et al., 2002).  
 
A pedigree chart was drawn to ascertain the Malay lineage, only those with three generation of 
Malay lineage without any interracial marriage were recruited. All PACG patients had laser 
peripheral iridotomy (LPI) done prior to the recruitment period. PACG patients with minimal 
four reliable and reproducible visual fields (VFs) including the current visual field (two VFs at 
the diagnosis and two VFs at current recruitment) were included. Patients were excluded if they 
have incomplete pedigree chart or unknown pedigree chart, any intraocular surgery other than 
cataract surgery that would affect the natural anatomy of anterior segment biometry or with 
history of pan-retinal photocoagulation laser therapy. Those with cataract of nuclear 
opalescence (NC) >2, cortical(C) >2 and posterior subcapsular(P) >2 based on Lens Opacities 
Classification System III (LOCSIII) (Hall et al., 1997) or severe corneal diseases that precluded 
adequate view of the anterior segment were also excluded. Written consent was obtained from 
selected patients prior to the commencement of the study. 
 
Comprehensive ocular examination including slit lamp examination, gonioscopic evaluation 
and intraocular pressure (IOP) measurement using Goldmann Applanation Tonometry (GAT) 
was conducted to rule out secondary causes of glaucoma including secondary angle closure. 
Posterior segment was also evaluated to exclude patients with non-glaucomatous optic 
neuropathy or retinal diseases affecting interpretation of visual field. Refractive assessment 
was also conducted to exclude patients with high refractive error; spherical equivalent < -8 or 
> +4 Diopter. Medical records were also retrieved to obtain data on duration and treatment of 
PACG, history of APAC, and systemic co-morbidities (e.g. diabetes mellitus, hypertension, 
dyslipidaemia and ischaemic heart disease). Direct face-to-face interview was conducted to 
obtain information on education level and family history of glaucoma. If both eyes fulfil the 
selection criteria, only right eye was selected.   
 
Humphrey visual field (HVF) 24-2 analysis was conducted during recruitment period and 
another repeated HVF evaluation was conducted a month after the recruitment period. Reliable 
visual field was based on fulfilling criterias of ≤33% fixation losses, ≤33% false-negative 
results, and ≤33% false-positive results. Another repeat HVF was conducted within six months 
of recruitment period, if the second HVF is not reliable or reproducible. Two reliable 
reproducible consecutive HVF within six months of the diagnosis of PACG were retrieved 
from the medical record.  Progression is based on HVF changes using Hodapp, Parrish and 
Anderson’s (HPA) classification. Primary investigator (NPF) and glaucoma specialist (LS) 
were responsible in analyzing the HVF. The definition of progression was based on the 
agreement of both investigators. Based on HPA classification, PACG patients were divided 
into progress and non-progress group.  
 
Ocular biometry measurement was conducted by a trained optometrist who was blinded from 
the HVF analysis. Axial length and anterior chamber depth (ACD) was measured using a 
noncontact partial coherence interferometer (IOL Master, Carl Zeiss, Germany). Anterior 
segment optical coherent tomography (AS-OCT) (Spectralis Heidelberg, Germany) was used 
to measure and anterior chamber angle (ACA) without pupil dilation in standard illumination 
conditions. A total of five images were obtained. The best image was chosen based on the 
operator best judgement. The most important criteria was the absence without of motion or 
image artifacts. Measurement from identified scleral spur was conducted by another blinded 
investigator.  
 
 Statistical analysis 
All data were analysed using Statistical Package for Social Sciences (SPSS) for Windows 
Version 22. Descriptive statistics was performed to analyse the demographic data. Independent 
t-test was used to compare the anterior segment biometry parameters between progress and 
non-progress Malay patients with PACG. p-value <0.05 was deemed as statistically significant. 
Multivariate ANOVA analysis was used to compare the anterior segment parameters between 
progress and non-progress PACG patients, with adjustment for intraocular pressure, lens status, 
age, education level and number of acute primary angle closure attack. 
 
 
 
 
3.5 Results 
A total of 43 Malay patients with PACG were included in this study. 27 patients fulfilled the 
criteria for progression of PACG after mean duration of follow up 6.90 (SD 3.60) years. There 
was no significant difference found in the demographic data of PACG patients between the 
progress and non-progress group except for mean intraocular pressure, education level and 
numbers of acute primary angle closure (APAC) (Table 1 & 2). This suggested that both groups 
of patients were relatively comparable. In this study, the non-progress group of patients were 
significantly more educated (p=0.001). (Table 1). It was also observed that out of the 43 PACG 
patients, 15 patients presented with APAC, representing 34.9% of total PACG Malay patients 
and 53.6% of the progress group. There was significant higher number of patients with history 
of APAC in the progress group (p= 0.048) (Table 2). 
 
Malay PACG patients with progression have significant narrower mean ACA (11.96°±6.00) as 
compare to non-progress group (mean ACA = 19.04°±5.18) (p<0.001) (Table 3). Otherwise, 
comparison of other anterior segments parameters (AL and ACD) were reported no significant 
difference between progress and non-progress Malay patients with PACG (Table 3). 
 
After adjusting for confounding factors such as intraocular pressure, lens status, age, education 
level and number of acute primary angle closure attack, ACA remained statistically difference 
in between progress and non-progress PACG patients. Meanwhile other parameters such as AL 
and ACD remain insignificant (Table 4). 
 
3.6 Discussion 
PACG is a potentially blinding disease that can be halted by early diagnosis and treatment.  
Most knowledge on burden, risk factors and knowledge on anterior segment biometry in PACG 
has been derived from high risk population such as Chinese, Japanese and Indian population 
(Table 5) (Congdon et al., 1997; George et al., 2003; Hayashi et al., 2000; Liang et al., 2011; 
Thomas et al., 2003). Malays account for 5% of the world’s population ("Population Reference 
Bureau ", 2016) and more than 50% of the population in Malaysia (Department of Statistics, 
2010). The progression rate of PACG has been found to be higher in Malays when compared 
to Chinese (Liza-Sharmini et al., 2009). Established biometric risk factors for PACG include 
hyperopia, a short AL, shallow anterior chamber depth (ACD), and increased lens thickness 
(Bonomi et al., 2000; Dandona et al., 2000; Lavanya et al., 2008; Thapa et al., 2011). Anterior 
segment biometry is associated with progression of PACG (Fan et al., 2013). Literature 
concerning the role of anterior segment biometry in progression of angle-closure glaucoma is 
limited.   
 
In our study, the only significantly different parameter between PACG patients with and 
without progression was ACA, even after adjustment for confounders. We found that Malay 
patients with PACG who developed progression had significant narrower ACA than non-
progressed patients. Although ACA is an important component in anterior segment biometry, 
knowledge on ACA in PACG progression is still sparse, with no other study evaluating ACA 
between PACG eyes with and without progression (Table 5). This may be due to the limited 
availability of modalities for assessment of anterior segment biometry especially in the rural 
areas or in poor developing countries.  
 
ACA may be a better predictor for development of iridotrabecular contact (ITC), as there is 
direct correlation between degree of ITC and PAS formation (Bhargava et al., 1973; Mishima 
et al., 2013). Thus, ACA may be indirectly associated with progression of PACG. Coexistence 
of PAS and appositional closure is the main factor contributing factor to a persistently narrow 
ACA even after treatment (Nolan et al., 2000; Ramani et al., 2009).  A population-based 
intervention study has shown that despite a significant increase in the angle width following 
laser iridotomy, one-fifth of patients with PACS continue to have appositional angle closure 
(He et al., 2007).  
 
In the current study, progress group had a significantly higher mean IOP compared to non-
progress group. IOP is directly related with progression (Aung et al., 2000; Quek et al., 2011). 
Changes in IOP may impose a direct mechanical effect on optic nerve head or indirectly cause 
impairment in ocular perfusion pressure (Agarwal et al., 2009; Downs et al., 2008). IOP 
reduction in patients with CACG may prevent progressive visual field and optic disc damage 
(Sharmini et al., 2009). After adjusting for the effect of IOP, we found that the difference in 
ACA between PACG patients with and without progression remained statistically significant, 
suggesting that progression may be related to anterior segment biometry, independent of IOP. 
 
The group with progression had a higher number of APAC. We postulated this may be due to 
lack of awareness and understanding of the disease that may lead to late presentation. As this 
group had a high illiteracy rate, they tended to refuse or be poorly compliant to treatment. This 
is in contrast to another hospital-based study, which found that subjects with asymptomatic 
PACG present with more severe VF loss than those with symptomatic disease (Ang et al., 
2004). Most likely, our patients with APAC had element of acute on chronic presentation 
(Douglas et al., 1975; Liza-Sharmini et al., 2014).  
 
Biometric studies have shown that PACG is associated with shorter axial length (AL) (Foster, 
2002; Lowe, 1970; Seah et al., 1997; Wong et al., 2000). A shorter AL was identified as a risk 
factor for progressive VF defects in Chinese patients under treatment for PACG (Fan et al., 
2013). Generally, AL is considered as a vital component in ocular biometry. In view of its close 
relation with anterior segment biometry, it was evaluated in our subjects as well. Interestingly, 
there was no significant difference in AL between progress and non-progress patients in our 
study. AL of the eye ball is the distance from the posterior corneal surface to an interference 
peak corresponding to retinal pigment epithelium/Bruch's membrane (Hitzenberger, 1991). It 
is the total length of ACD, lens thickness (LT) and vitreous length (Chiotoroiu et al.). In a 
recent study, Kai-Ling Yong et al deduce that their myopic Asian subjects with angle closure 
are predominantly axial myopes with long VL (Yong et al., 2014). The study suggested that 
despite having longer AL, the characteristics of the anterior segment of their eyes are similar 
to those of hyperopes and emmetropes. Hence, shorter AL is not equivalent to overcrowding 
of anterior segment or vice versa. This might explain why there was significant difference in 
AL between progress and non-progress PACG patients.  
 
ACD is measured along posterior corneal surface to the anterior pole of the lens (Hitzenberger, 
1991). It is believed that ACD is a cardinal risk factor for angle closure (Jonas et al., 2012). 
We observed that comparison of ACD in progress and non-progress patients were statistically 
insignificant in this study. Although ACD can potentially be affected by lens status, the ACD 
remained an insignificant parameter even after adjustment for phakic status (Hayashi et al., 
2000; Steuhl et al., 1992; Yang and Hung, 1997). This was further supported by studies 
conducted by Quek et al and Fan et al; ACD was not associated with VF progression (Fan et 
al., 2013; Quek et al., 2011).  
 
Major limitation in this study is the inclusion of both pseudophakic and phakic patients. 
Pseudophakia causes changes in ocular biometry (Dawczynski et al., 2007; Kasai et al., 2015; 
Memarzadeh et al., 2007; Nonaka et al., 2006). In a prospective comparative observational 
case series by Mermazader et al, it showed that morphology of anterior segment biometry 
changed after cataract surgery. This included flattening of the convex iris configuration and 
widening of ACD and ACA (Memarzadeh et al., 2007). Another study also demonstrated that 
increased in ACD and ACA after cataract surgery with intraocular lens implantation 
(Dawczynski et al., 2007). Lens exteraction also causes further reduction of IOP (Azuara-
Blanco et al., 2016). Majority of our patients were pseudophakic, 75% in progress group and 
46.7% in non-progress group. In spite of the benefit of lens extraction to ocular biometry and 
IOP reduction, majority of our patients still progressed. In addition, lens thickness was not 
identified as a risk factor for visual field progression in PACG patients, a finding from 
retrospective cohort study (Fan et al., 2013).  
 
Another limitation of this study is relative small sample size. Ability to comply to follow up or 
visual field assessment was an arduous task in Kelantan. Moreover, most patients were elderly 
with low education level, and were unable to produce an acceptable VF for evaluation (Liza-
Sharmini et al., 2014; Saw et al., 2003). Hence, we faced difficulty in recruiting subjects that 
fulfilled the inclusion and exclusion criteria for our study. At the beginning of recruitment 
period, we identified 63 eligible PACG patients. However, after reviewing the HVF, 17 patients 
were excluded and another 3 patients failed to provide an acceptable OCT image.  
 
In conclusion, evaluating anterior segment biometry parameters shared an important value in 
predicting risk of progression in Malay PACG. ACA is the significant predictor for progression 
of PACG. In the future, prospective study with larger sample size may provide conclusive 
finding on the role of ocular biometry in progression of PACG.  
Conflicts of interest: The authors declare that they have no conflict of interest. 
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3.8 Tables  
3.8.1 Table 1:  Demographic data of Malay PACG patients  
Variables 
 
 Malay PACG (N=43)  p-value 
Progress 
(N=27) 
Non-progress 
(N=16) 
 
Mean age 
YearsSD 
64.181.83 62.732.36    0.632^ 
 
Gender (n, %) 
Male 
Female 
 
 
13 (46.4%) 
15 (53.6%) 
 
 
9 (60.0%) 
6 (40.0%) 
  
 
0.396# 
 
Systemic disease (n, %) 
Diabetes mellitus 
Hypertension 
Hyperlipidemia 
Ischemic heart disease 
 
Educational level (n, %) 
No formal education 
Primary 
Secondary 
Tertiary 
 
 
21 (75.0%) 
19 (67.9%) 
22 (78.6%) 
14 (50.0%) 
 
 
10 (35.4) 
14 (50.0) 
4 (14.3) 
0 (0.00) 
 
 
12 (80.0%) 
12 (80.0%) 
13 (86.7%) 
5 (33.3%) 
 
 
0 (0.00) 
5 (33.3) 
7 (46.7) 
3 (20.0) 
  
 
0.711# 
0.398# 
0.516# 
0.294# 
 
 
0.001# 
 
# Pearson Chi-square test (p<0.05 is significant) 
^ Independent T test (p<0.05 is significant) 
3.8.2 Table 2: Comparison of glaucoma related history and clinical features between 
progress and non-progress Malay PACG patients 
 
Variables Malay PACG (N=43)  p-value 
Progress 
(N=27) 
Non-progress 
(N=16) 
 
     
Mean duration of 
PACG Years 
 
Family history of 
glaucoma (n, %) 
 
APAC(n, %) 
 
 
Mean IOP (mmHg) 
 
Lens status (n, %) 
Phakic 
5.54 
 
 
5 (17.9%) 
 
 
15 (53.6%) 
 
 
18 
 
 
7 (25.0%) 
5.80 
 
 
4 (26.7%) 
 
 
6 (40.0%) 
 
 
 
14 
 
 
8 (53.3%) 
 
 0.719^ 
 
 
0.499# 
 
 
0.048# 
 
 
0.034# 
 
 
0.063# 
 
APAC- acute primary angle closure 
^Independent T test (p<0.05 is significant) 
# Pearson Chi-square test (p<0.05 is significant) 
3.8.3 Table 3:  Comparison of anterior segment biometry parameters in progress and 
non-progress Malay PACG patients 
 
Variables PACG (N=43)  p-value 
Progress 
(N=27) 
Non-progress 
(N=16) 
 
Anterior segment 
biometry parameters 
MeanSD 
    
 
AL (mm) 
 
ACD (mm) 
 
ACA (°) 
 
 
22.470.55 
 
2.700.78 
 
11.966.00 
 
22.890.50 
 
2.920.66 
 
19.045.18 
  
0.071^ 
 
0.197^ 
 
<0.001^ 
 
 
^Independent T test (p<0.05 is significant) 
 
 
 
 
 
 
3.8.4 Table 4:  Comparison of anterior segment biometry parameters in progress and 
non-progress Malay PACG patients 
  
Variables PACG (N=43)  p-value* 
 Progress 
(N=27) 
Non-progress 
(N=16) 
F-stat 
(df) 
Anterior segment 
biometry parameters 
MeanSD 
    
 
AL (mm) 
 
ACD (mm) 
 
 ACA (°) 
 
22.530.82 
 
2.750.59 
 
13.575.98 
 
22.290.62 
 
2.470.35 
 
7.142.61 
 
2.750(1) 
 
 
1.075(1) 
 
 
 
19.028(1) 
 
0.159*  
 
0.062* 
 
<0.001* 
 
 
* MANOVA test (p<0.05 is significant) 
*Model adjusted for age, lens status, educational level and episodes of acute angle closure 
attack (APAC) 
 
 
 
 
 
3.8.5 Table 5: Comparison of PACG patients between ethnicities 
 
Study Current Liang et al., 
2011 
Congdon et al., 1997 George et al., 2003 Hayashi et al., 2000 
Ethnicity Malay 
 
China 
Chinese 
Caucasian African 
American 
Taiwanese 
Chinese 
Indian Japanese 
Number of 
subjects (n) 
43 32 N/A N/A 14 22 73 
Mean Age  63.67± 9.43 65.8± 11.7 N/A N/A > 40 57.42 73.5± 2.3 
Male:Female 1:1 1:1.67 N/A N/A N/A 2:20 1:2.67 
LT (mm) N/A 4.96 ± 0.41 N/A N/A N/A 4.24 ± 0.69 N/A 
ACA (°) 14.43 ± 6.62 N/A N/A N/A N/A N/A N/A 
AL (mm) 
ACD (mm) 
22.62 ± 0.76 
2.77 ± 0.54 
22.30 ± 0.60 
2.30 ± 0.35 
23.32 ±1.07 
3.03 ±0.31 
23.14±0.87 
3.01 ±0.29 
23.35±1.38 
3.02± 0.30 
21.92 ± 0.7 
2.63 ± 0.39 
N/A 
18.9 ± 4.0 
 
N/A, not available 
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American Academy of Ophthalmology Journal 
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Parameters Between Progress and Non-Progress Primary Angle Closure Glaucoma In 
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Academy of Ophthalmology Journal. 
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4.2 Abstract 
Objective: To compare anterior segment biometry parameters in progress and non-progress 
primary angle closure glaucoma (PACG) among Malay and Chinese patients. 
Design: A cross-sectional study. 
Participants: A total of 75 patients which include 43 Malay PACG patients and 32 Chinese 
PACG patients that fulfilled inclusion and exclusion criteria were recruited from a single 
glaucoma centre in Malaysia. 
Methods: Malay and Chinese PACG patients were recruited between November 2015 and 
December 2016. Ocular examination included anterior segment biometry measurements on the 
selected eye. Axial length (AL) measurement and anterior chamber depth (ACD) was done 
using a noncontact partial coherence interferometer (IOL Master, Carl Zeiss, Germany). 
Anterior chamber angle (ACA) was measured by Anterior Segment-OCT (Spectralis 
Heidelberg, Germany). Humphrey visual field (HVF) 24-2 analysis of the same eye was done. 
Based on 2 consecutives reliable HVFs, the progression of PACG patients was assessed 
according to the Hodapp, Parrish and Anderson’s (HPA) classification. According to HPA 
definition, patients were divided into progress and non-progress groups. Comparison of 
anterior segment biometry parameters between Malay and Chinese PACG patients with and 
without progression was analysed using independent T test. Multivariate ANOVA analysis was 
used to compare the anterior segment parameters between progress and non-progress PACG 
patients, with adjustment for age, gender, lens status, family history and presence of diabetes 
mellitus. 
Main Outcome Measures: Ocular biometry measurement: AL, ACD and ACA 
Results: Chinese PACG patients have significant shorter AL (22.18mm±0.76) and narrower 
ACA (11.96°±6.00) compared to Malay PACG patients. Among the progress group, Chinese 
PACG patients have significant shorter AL, shallower ACD and narrower ACA compared to 
Malays. However, after controlling for confounding factors, there was significant difference in 
ACA between Malay and Chinese PACG. There was also no significant difference of ocular 
biometry measurement between Chinese and Malay patients in progress and non-progress 
group.  
 
Conclusions:  
There was racial influence in ocular biometry measurement in PACG patients. Chinese has 
significant narrower ACA compared to Malays. Serial AS-OCT monitoring is important in 
management of PACG. 
 
4.3 Introduction  
Primary angle closure glaucoma (PACG) is characterized as a chronic, progressive visual field 
loss and optic nerve cupping, often associated with an elevated intraocular pressure (IOP) due 
to the presence of iridotrabecular contact (ITC) by gonioscopy, which can either be 
appositional or synechial, in the absence of underlying secondary ocular disease (European 
Glaucoma Society, 2014). Ethnic or geographic differences in the prevalence rates of PACG 
are well known, with relatively high prevalence rates 1.1%-2.0% in Chinese (He et al., 2006b; 
Sawaguchi et al., 2012), Mongol 1.4% (Foster et al., 1996), Thai 0.9% (Bourne et al., 2003), 
Nepal 0.39% (Thapa et al., 2012) and Singaporean Chinese 1.1% (Foster et al., 2000b).  
 
The prevalence of PACG in Malays was 0.12% based on the Singapore Malay Eye Study 
(SiMES) that involved 3280 participants aged 40 to 80 years (Shen et al., 2008). There is 
minimal knowledge regarding the presentation of PACG in Malays. Majority of the studies 
were retrospective in nature (Liza-Sharmini et al., 2014; Sharmini et al., 2009). Progression 
rate of PACG was higher in Malays in Malaysia compared to Chinese in Malaysia, Taiwan and 
Hong Kong (Liza-Sharmini et al., 2009). This observation was made on a small number of 
Malays in Malaysia. In another retrospective study, Malays demonstrated 16 folds (95% CI, 
p=0.001) increased risk of progression in the presence of glaucomatous optic disc (Liza-
Sharmini et al., 2014). On comparison with Chinese patients treated in another tertiary center 
in Malaysia, Malays were found to present with advanced disease, older age, higher baseline 
IOP and progressed faster than Chinese (Liza-Sharmini et al., 2014). In retrospective 
observational case series based on Chinese population in Singapore, a third of eyes with PACG 
experienced VF deterioration over 10 years, with 7% progressing to blindness while on 
treatment. Eyes with higher mean overall IOP and a history of previous AAC were more likely 
to have VF progression (Quek et al., 2011). 
 
Late presentation and poor awareness may contribute to the higher rate of progression among 
Malays. However, there is possibility of racial differences play a role in the course of the 
disease (Cheng et al., 2014; He et al., 2006b). Perhaps, genetics play a role in determination of 
progression and ocular biometry (Vithana et al., 2012). Ocular biometry has been identified as 
non-modifiable risk factor for PACG (Foster, 2002; Lowe, 1970; Seah et al., 1997; Sherpa and 
Badhu, 2008; Wong et al., 2000). Anterior segment biometry; shorter axial length (AL), 
shallow anterior chamber depth (ACD) and small anterior chamber angle (ACA) has been 
identified to increase risk of PACG (Foster et al., 2002; Foster et al., 2000c; Sherpa and Badhu, 
2008; Thapa et al., 2011). Perhaps, anterior segment biometry plays a role as risk factor for 
progression. 
 
Shallower anterior chamber increases the risk of formation of peripheral anterior synechaie 
(PAS) that may lead to further IOP elevation and progression of PACG (Choi and Kim, 2004; 
Foster et al., 2000a; Sharon et al., 2016) . The aim of this study was to compare the anterior 
segment biometry parameters between progress and non-progress PACG patients among 
Malay and Chinese. Factors affecting the progression of PACG in Malays and Chinese were 
also evaluated in this study 
 
4.4 Methods 
Patient recruitment 
A cross sectional study was conducted between November 2015 and December 2016. A total 
75 PACG patients (43 Malays and 32 Chinese) were recruited from a tertiary centre; 
Ophthalmology Clinic in Hospital Universiti Sains Malaysia (HUSM). This study received 
ethical approval from Research and Ethical Committee, School of Medical Sciences, Universiti 
Sains Malaysia (USM/JEPeM/15060236) and was conducted in accordance to Declaration of 
Helsinki for human research.  
 
The current classification of PACG is based on clinical observations in European populations 
and can be classified into three types; Primary angle closure suspect (PACS), Primary angle 
closure (PAC) and PACG. PACS is defined as an eye in which 180o or more appositional 
contact between the peripheral iris and posterior trabecular meshwork is considered possible 
with normal IOP, no peripheral anterior synechiae (PAS) and no evidence of glaucomatous 
optic neuropathy (GON). PAC is defined as an eye with 180o or more occludable drainage 
angle and features indication that trabecular obstruction by the peripheral iris has occurred, 
such as raised IOP of more than 21 mmHg, PAS, iris whirling, “glaucomflecken” lens 
opacities, or excessive pigment deposition on the trabecular surface in the absence of GON. 
The term PACG is used to indicate PAC eyes with GON ("European Glaucoma Society," 2014; 
Foster et al., 2002).  
 
A pedigree chart was drawn to ascertain the Malay and Chinese lineage, only those with three 
generation of Malay and Chinese lineage without any interracial marriage were recruited. 
PACG patients with minimal four reliable and reproducible visual fields (VFs) including the 
current visual field (two VFs at the diagnosis and two VFs at current recruitment) were 
included. All PACG patients had laser peripheral iridotomy (LPI) done prior to the recruitment 
period. Patients were excluded if they have incomplete pedigree chart or unknown pedigree 
chart, any intraocular surgery other than cataract surgery that may affect the natural anatomy 
of anterior segment biometry or with history of pan-retinal photocoagulation laser therapy. 
Those with cataract of nuclear opalescence (NC) >2, cortical(C) >2 and posterior subcapsular 
(P) >2 based on Lens Opacities Classification System III (LOCSIII) (Hall et al., 1997b) or 
severe corneal diseases that precluded adequate view of the anterior segment were also 
excluded. Written consent was obtained from selected patients prior to the commencement of 
the study. 
 
Comprehensive ocular examination including slit lamp examination, gonioscopic evaluation 
and intraocular pressure (IOP) measurement using Goldmann Applanation Tonometry (GAT) 
was conducted to rule out secondary causes of glaucoma including secondary angle closure. 
Posterior segment was also evaluated to identify non-glaucomatous optic neuropathy or retinal 
diseases affecting interpretation of visual field. Refractive assessment was also conducted to 
exclude patients with high refractive error; spherical equivalent < -8 or > +4 Diopter. If both 
eyes fulfil the selection criteria, only right eye was selected.  Medical records were also 
retrieved to obtain data on duration and treatment of PACG, history of APAC, and systemic 
co-morbidities (e.g. diabetes mellitus, hypertension, dyslipidaemia and ischaemic heart 
disease). Direct face-to-face interview was conducted to obtain information on education level 
and family history of glaucoma.  
Humphrey visual field (HVF) 24-2 analysis was conducted during recruitment period and 
another repeated HVF evaluation was conducted a month after the recruitment period. Reliable 
visual field was based on fulfilling criteria of ≤33% fixation losses, ≤33% false-negative 
results, and ≤33% false-positive results. Another repeat HVF was conducted within six months 
of recruitment period, if the second HVF is not reliable or reproducible. Two reliable 
reproducible consecutive HVF within six months of the diagnosis of PACG were retrieved 
from the medical record.  Progression is based on HVF changes using Hodapp, Parrish and 
Anderson’s (HPA) classification. Primary investigator (NPF) and glaucoma specialist (LS) 
were responsible in analyzing the HVF. The definition of progression was based on the 
agreement of both investigators. Based on HPA classification, PACG patients were divided 
into progress and non-progress group.  
 
Ocular biometry measurement was conducted by a trained optometrist who was blinded from 
the HVF analysis. Axial length and anterior chamber depth (ACD) was measured using a 
noncontact partial coherence interferometer (IOL Master, Carl Zeiss, Germany). Anterior 
segment optical coherent tomography (AS-OCT) (Spectralis Heidelberg, Germany) was used 
to measure the and anterior chamber angle (ACA) without pupil dilation in standard 
illumination conditions. A minimum of five images were obtained. The best image was chosen 
based on the operator (optometrist) best judgement without the presence of motion artifacts or 
image artifacts. Measurement from identified scleral spur was conducted by another blinded 
investigator (AY).  
 
Statistical analysis 
All data were analysed using Statistical Package for Social Sciences (SPSS) for Windows 
Version 22. Descriptive statistics was performed to analyse the demographic data. Independent 
t-test was used to compare the anterior segment biometry parameters between Malay and 
Chinese patients with and without progression of PACG. A p-value of less than 0.05 was 
deemed as statistically significant. Multivariate ANOVA analysis was used to compare the 
anterior segment parameters between progress and non-progress PACG patients, with 
adjustment for age, gender, lens status, family history and presence of diabetes mellitus. 
 
4.5 Results 
Chinese patients with PACG were significantly older (p=0.035) (Table 1). There was a 
significant predilection towards females among Chinese patients with PACG with a ratio of 
2.5:1 (Table 1). Duration of the disease was significantly longer among the Malays compared 
to Chinese (p =0.032) (Table 2). There was higher number of Chinese patients (53.1 %) with 
positive family history of PACG compared to Malays (20.9%) (Table 2). However, there was 
significant different in the presence of APAC between the two races (Table 2).  
 
Chinese patients with PACG have significantly shorter AL (22.18mm±0.76) and narrower 
ACA (11.96°±6.00) compared to Malays (Table 3). However, after adjustment for age, gender, 
family history and presence of diabetes mellitus and lens status, only ACA differed 
significantly between Chinese and Malays (Table 3). In the progress group, Chinese patients 
have significant shorter AL, shallower ACD and smaller ACA compared to Malays (Table 4). 
However, after controlling for confounding factors, there was no significant difference (Table 
4). There was no significant different in anterior segment biometry between Malay and Chinese 
PACG patients in the non-progress group (Table 5). 
 
 
 
4.6 Discussion 
Hyperopia, short AL, shallow ACD, and increased lens thickness (Bonomi et al., 2000; 
Dandona et al., 2000; Lavanya et al., 2008; Thapa et al., 2011) have been identified as ocular 
biometric changes associated with risk of PACG. Previous studies found that ocular biometry 
of PACG differ from normal subjects in Chinese population (Lowe, 1969; Lowe, 1970; Lowe, 
1977; Nongpiur et al., 2011). However, there is no comparison of ocular biometry between 
different races in Asian. 
 
Based on our study, there was statistically significant difference of AL and ACA between 
Malays and Chinese. Chinese patients with PACG have significant shorter axial length and 
smaller ACA. However, there was no difference in ACD between Chinese and Malays PACG 
patients. ACD has been reported as the strongest predictor for PACG (Lavanya et al., 2008). 
As ACD is measured from corneal epithelium and lens, lens plays an important role as 
determinant (Nongpiur et al., 2011).  
 
In the present study, we included pseudophakic and phakic patients. Majority of our recruited 
Chinese patients with PACG (81.2%) were pseudophakic, while 34.9% of Malay patients with 
PACG patients were phakic. Pseudophakia caused changes in ocular biometry (Nonaka et al., 
2006; Memarzadeh,et al. 2007; Dawczynski et al., 2007; Kasai et al, 2015 ). In a prospective 
comparative observational case series by Mermazader et al, it showed that morphology of 
anterior segment biometry changed after cataract surgery. This included flattening of the 
convex iris configuration and widening of ACD and ACA (Memarzadeh et al, 2007). Another 
study also demonstrated that increased in ACD and ACA after cataract surgery with intraocular 
lens implantation (Dawczynski et al., 2007). Apart from this, lens position might have greater 
influences on angle width than lens thickness (Mermazader et al, 2007).  
In addition, a significantly higher number of Chinese patients with diabetes mellitus may lead 
to inaccuracy. Diabetes mellitus is known to cause swelling of the lens and cornea that may 
cause falsely shallower ACD (Saito et al., 1993; Sonmez et al., 2005). Moreover, the duration 
of post cataract extraction surgery was not included in the present study. In a recent randomized 
control trial, it demonstrated the lowering of IOP by lens extraction (Azuara-Blanco et al., 
2016). Clear lens extraction showed effective greater efficacy and was more cost effective than 
laser peripheral iridotomy in lowering IOP in PACG patients (Azuara-Blanco et al., 2016).   
 
On the other hand, there was no significant different of ACD between Chinese, Caucasians and 
Blacks (Congdon et al., 1992; Congdon et al., 1997). Based on study conducted by Congdon 
et al, the radius of corneal curvature was significant smaller among Chinese compared to the 
other 2 groups (Congdon et al., 1997). The radius of corneal curvature represents crowded 
anterior chamber and angle rather than shallow ACD. In addition, ACD measures the central 
chamber depth but not peripheral. It is postulated that pathogenesis of angle closure in Chinese 
population is due to crowding of peripheral anterior chamber, plateau iris configuration, or a 
combination of these with presence of pupillary block, rather than pure pupillary block (Nolan 
et al., 2006) . 
 
After controlling for confounding factors such as age, gender, family history, lens status and 
presence of diabetes mellitus, there was significant difference of ACA between Malays and 
Chinese patients with PACG. There were minimal studies that include ACA in their ocular 
biometry assessment (Friedman, 2008; Leung et al., 2010; Radhakrishnan et al., 2005). 
Perhaps, this is due to the difference in technique of biometry assessment; as AS-OCT is a new 
imaging tool. ACA may provide better predictor for development of iridotrabecular contact 
(ITC). There was direct correlation between degree of ITC and PAS formation (Bhargava et 
al., 1973; Mishima et al., 2013). This may be indirectly associated with progression of PACG.   
 
Based on our finding, Chinese patients who developed visual field progression had relatively 
shorter AL, shallower ACD and narrower ACA compared to Malays. However, after 
controlling for confounding factors, there was no significant difference of AL, ACD and ACA 
between Malays and Chinese PACG patients with progression. Shorter AL was found as 
predictor for progression VF defects in Chinese patients with PACG (Fan et al., 2013). Shorter 
AL is associated with greater circadian and postural related changes in habitual IOP (Loewen 
et al., 2010) (Wilson et al., 2006). Changes in IOP may impose direct mechanical effect on 
optic nerve head or indirectly causing impairment in ocular perfusion pressure (Agarwal et al., 
2009; Downs et al., 2008) . On contrary, the mean IOP was higher in Malay patients compared 
to Chinese. There was no documentation of IOP control throughout the entire duration of the 
disease. In the present study, we assumed that the IOP was well controlled and achieved target 
IOP. PACG patients are known to develop wide fluctuation of IOP especially those with acute 
on chronic type of presentation (Baskaran et al., 2009; Sihota et al., 2001).  
 
On the other hand, Chinese patients were significantly older compared to Malays. Increasing 
age was found to be associated with decreasing AL and ACD (Hashemi et al., 2009; He et al., 
2008; Salmon et al., 1993; Xu et al., 2008) . Moreover, there were a higher number of men 
who developed PACG among Malays patients.  Men are known to have deeper ACD and wider 
ACA (Hu, 1989a; Luntz, 1973; Salmon, 1993; Xu et al., 2008). Women are more at risk to 
develop progression of PACG (Quek et al., 2011), partially due to the overcrowding of anterior 
chamber (Wong et al., 2001). The difference of ocular biometry between races most likely 
related to genetic predisposition to development and progression of the disease (Vithana et al., 
2012; Wang et al., 2002). The complexity of PACG; intermingle of genetics, environmental 
and other potential causes make the understanding of the disease more interesting.  
 
Understanding the effect of ocular biometry changes in the progression of chronic disease like 
PACG is not possible with a cross sectional study. Perhaps, prospective study will be more 
appropriate methodology. The recruitment should begin at the diagnosis and AS-OCT should 
be conducted as routine with serial assessment throughout the follow up period. Furthermore, 
the sample size was relatively small especially after dividing into progress and non-progress 
group. This is partly due to inability to obtain reliable and reproducible VF at the baseline. Low 
education level and learning curve may affect the accuracy of VF analysis. In view of the 
multifactorial components that can contribute to this blinding disease, small sample sizes in 
our study might unable to represent the exact population. Moreover, using Hodapp, Parrish and 
Anderson classification to detect VF progression is not an ideal technique (Susanna Jr and 
Vessani, 2009). However, the current study may provide useful insight in understanding PACG 
in Malays. 
  
Conclusion 
Ocular biometry may influence by the racial differences in Asians with PACG. Chinese has 
significant narrower ACA compared to Malays. However, the influence of ocular biometry in 
progression of PACG is still inconclusive. Serial AS-OCT monitoring is important in 
management of PACG. 
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4.8 Tables 
4.8.1 Table 1: Demographic data of Malay and Chinese PACG patients  
Variables PACG (N=75)  p-value 
Malay 
(N=43) 
Chinese 
(N=32) 
 
Mean age years 63.7±9.4 68.6 ±10.0    0.035^ 
Gender (n, %) 
Male 
Female 
 
22 (51.2%) 
21 (48.8%) 
 
9 (28.1%) 
23 (71.9%) 
  
0.045# 
 
Systemic disease (n, %) 
Diabetes mellitus 
Hypertension 
Hyperlipidemia 
Ischemic heart diseas 
 
Educational level (n, %) 
No formal education 
Primary 
Secondary 
Tertiary 
 
 
33 (76.7%) 
31 (72.1%) 
35 (81.4%) 
16 (37.2%) 
 
  
9 (20.9%) 
17 (39.5%) 
13 (30.2%) 
4 (9.3%) 
 
 
12 (37.5%) 
27 (84.4%) 
25 (78.1%) 
13 (40.6 %) 
 
 
5 (15.6%) 
19 (59.4%) 
7 (21.9%) 
1 (3.1%) 
  
 
0.001# 
0.209# 
0.726# 
0.294 # 
 
 
0.346# 
# Pearson Chi-square test (p<0.05 is significant) 
^ Independent T test (p<0.05 is significant) 
4.8.2 Table 2: Comparison of glaucoma related history and clinical features in Malay and 
Chinese PACG patients 
 
Variables PACG (N=75)  p-value 
Malay 
(N=43) 
Chinese 
(N=32) 
 
     
Mean duration  
of PACG years 
 
Family history  
of glaucoma (n, %) 
 
APAC 
 
 
Mean IOP (mmHg) 
 
 
Lens status (n, %) 
Phakic 
6.90 ±3.6 
 
 
9 (20.9%) 
 
 
23 (53.5%) 
 
 
17 
 
 
 
5 (34.9%) 
5.30±2.7 
 
 
17 (53.1%) 
 
 
13 (40.6%) 
 
 
15 
 
 
 
6 (18.8%) 
 0.032^ 
 
 
0.004# 
 
 
0.270# 
 
 
0.064# 
 
 
 
0.124 # 
 
APAC – acute primary angle closure 
^Independent T test (p<0.05 is significant) 
# Pearson Chi-square test (p<0.05 is significant) 
4.8.3 Table 3: Comparison of anterior segment biometry parameters between Malay and 
Chinese PACG patients 
 
Variables PACG (N=75)  p-value^ p-value* 
Malay  
(N=43) 
Chinese  
(N=32) 
  
Anterior segment 
biometry 
parameters 
MeanSD 
 
 
     
 AL (mm) 
 
 ACD (mm) 
 
ACA (°) 
 
22.62±0.76 
 
      2.78±0.54 
 
     14.43±6.62 
 
22.18±0.87 
 
  2.61±0.53 
 
 11.58±5.32 
 
 
0.022^ 
 
  0.183^ 
 
  0.042^ 
0.124* 
 
   0.361* 
 
 
   0.041* 
 
^Independent T test (p<0.05 is significant) 
* MANOVA test (p<0.05 is significant) 
Model adjusted for age, gender, family history, lens status and presence of diabetes mellitus  
 
 
 
4.8.4 Table 4: Comparison of anterior segment biometry parameters in Malay and 
Chinese PACG patients with visual field progression 
 
Variables Progress PACG (N=47) p-         p-value*   value^ 
Malay  
(N=27) 
Chinese  
(N=20) 
  
Anterior segment 
biometry 
parameters 
MeanSD 
 
    
AL(mm) 
 
ACD (mm) 
 
ACA (°) 
 
22.47±0.78 
 
     2.70±0.55 
 
     11.96±6.00 
22.01±0.77 
 
   2.40±0.30 
 
    9.18±2.37 
0.047^ 
 
 0.020^ 
 
 0.032^ 
0.878* 
 
     0.345* 
 
     0.478* 
 
^Independent T test (p<0.05 is significant) 
* MANOVA test (p<0.05 is significant) 
Model adjusted for age, gender, lens status, family history and presence of diabetes mellitus  
 
 
 
 
4.8.5 Table 5: Comparison of anterior segment biometry parameters in non-progress 
Malay and Chinese PACG patients 
 
Variables Non-Progress PACG (N=28) p-value^ p-value* 
Malay  
(N=16) 
Chinese  
(N=12) 
  
Anterior segment 
biometry parameters 
YearsSD 
 
    
AL (mm) 
 
 
ACD (mm) 
 
 
ACA (°) 
 
22.89±0.66 
 
 
2.92±0.50 
 
 
19.04±5.18 
22.45±1.00 
 
 
2.96±0.64 
 
 
15.58±6.44 
0.184^ 
 
 
0.845^ 
 
 
0.135^ 
0.504* 
 
 
0.660* 
 
 
0.091* 
 
^Independent T test (p<0.05 is significant) 
* MANOVA test (p<0.05 is significant) 
Model adjusted for age, gender, lens status, family history and presence of diabetes mellitus  
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 1.0 INTRODUCTION 
Glaucoma is the second leading cause of blindness worldwide, following cataract (Quigley, 
1996; Thylefors et al., 1995). WHO has estimated that 4.5 million people are blind due to 
glaucoma (Quigley and Broman, 2006). It also projects that nearly half of the bilateral 
blindness attributable to glaucoma by 2020 will be caused by angle closure glaucoma. Based 
on the National Eye Survey conducted in Malaysia, glaucoma is the 5th major causes of 
blindness and low vision (Zainal et al., 2002). However, this study was likely to have 
underestimated the prevalence of glaucoma because the survey did not include refraction, slit 
lamp and visual examinations which are important examinations in detecting ocular diseases, 
such as glaucoma where visual acuity was preserved until late stage of the disease. 
 
Primary angle closure glaucoma (PACG) is defined as the presence of glaucomatous optic 
neuropathy in the presence of a narrow angle (Foster et al., 2002). It is the major form of 
glaucoma in Asia, and late presentation has been shown as the major contributory factor for 
blindness (Chen, 2004). Because of its high prevalence, especially in China and India, as well 
as its debilitating impact on vision, PACG is a significant cause of global visual morbidity 
(Dandona et al., 2000; Foster et al., 2002; He et al., 2006b; Jacob et al., 1998).  
 
The socioeconomic burden of visual loss secondary to this condition has spurred the search for 
risk factors which may contribute to the progression of the PACG. Up to the current date, risks 
factors for visual field (VF) progression in glaucoma have been mostly obtained from studies 
on open angle glaucoma, including Collaborative Initial Glaucoma Treatment Study (CIGTS), 
Collaborative Normal Tension Glaucoma Study, Advanced Glaucoma Intervention Study 
(AGIS), and Early Manifest Glaucoma Trial (EMGT). In contrast, there is limited data on risk 
factors associated with disease progression in PACG.  
Various contact and non-contact techniques have been utilized to evaluating the risks of 
progression in PACG. Gonioscopy is the clinical reference standard for evaluating the angle 
and detecting angle closure. Unfortunately, it is subjective and requires considerable skills and 
experience for accuracy. Less invasive methods of assessing the anterior segment including 
ultrasound biomicroscopy (UBM), Scheimpflug Photography (Pentacam) and Anterior 
Segment Optical Coherence Tomography (AS-OCT) have been gaining in popularity, 
especially as they provide quantitative, reproducible data. AS-OCT has been shown to offer 
precise anterior chamber angle (ACA) measurements and to detect more closed angles than 
gonioscopy (Nolan et al., 2007).  
 
Biometric studies have demonstrated a few parameters associated with progression of PACG. 
Eyes with acute primary angle closure glaucoma (APACG) have shallower anterior chambers 
(Lowe, 1970; Seah et al., 1997; Wong et al., 2000) and shorter axial lengths (AL) (Foster et 
al., 2002; Seah et al., 1997; Wong et al., 2000) than controls. In chronic PACG, Hong et al 
reported that patients with a thinner central corneal thickness (CCT) were at higher risk of VF 
progression than those with a thicker CCT. Other biometric parameters commonly associated 
with progression are as follows (Hong et al., 2007).  
 
(A) Axial length (AL) and PACG 
Ocular axial length is strongly associated with the incidence of primary angle closure. 
Biometric studies have shown that acute primary angle closure glaucoma is associated with 
shorter axial length (AL) (Foster, 2002; Lowe, 1970; Seah et al., 1997; Wong et al., 2000). 
Eyes with an axial length of less than 23 mm are at particular risk to develop primary angle 
closure glaucoma (Sherpa and Badhu, 2008). 
In the Bhaktapur Glaucoma Studies, eyes in the Nepalese population with occludable angle 
and angle-closure glaucoma appear to have significantly shallower anterior chambers and 
shorter axial lengths when compared with the normal group (Thapa et al., 2011). 
A shorter axial length (AL) was identified as a risk factor for progressive VF defects in Chinese 
patients under treatment for PACG (Fan et al., 2013). 
 
(B) Anterior chamber depth (ACD) and PACG 
Numerous studies revealed that shallower anterior chamber is one of the contributing factors 
for primary angle closure glaucoma. The association of anterior chamber depth with primary 
angle closure glaucoma is evidenced by a recent study evaluating anterior chamber depth in 
the East Asian population (Aung et al., 2005; Devereux et al., 2000). Moreover, according to 
an ocular biometric study published in 2013 (Chen YY, et al, 2013), shallower anterior chamber 
depth predisposes subjects with primary angle closure to progress to primary angle closure 
glaucoma. 
 
(C) Anterior chamber angle (ACA) and PACG 
According to Mohammad Pakravan, et al, individuals with anterior chamber angle ≤26° should 
have prophylactic laser peripheral iridectomy (LPI) as they are at high risk to develop primary 
angle closure attack, with a sensitivity of 77.3% and a specificity of 88.2% respectively. 
However, there is no much data to suggest such an arbitrary cutoff point for LPI (Pakravan et 
al., 2012). 
 
Wang et al 2002 reported that Chinese eyes are anatomically predisposed to PACG. However, 
among the above-mentioned ocular biometrics, axial length is the only ocular biometric 
parameter consistently associated with progression of PACG (Wang et al., 2002). ACD was 
not associated with VF progression in both Quek et al and Fan et al's study (Fan et al., 2013; 
Quek et al., 2011). However it is still studied in view of its close association with PACG. Up 
to date, there are no reports on the association of LT or ACD with progression of PACG, and 
the association of various anterior segment biometry parameters with progression of PACG up 
to date remains unconfirmed. 
 
Ethnic or geographic differences in the prevalence rates of PACG are well known, with 
relatively high prevalence rates (1.1%-2.0%) in Chinese, Mongolian, and Singaporean Chinese 
(Sawaguchi et al., 2012). Studies show that the Chinese population is one of the most at risk 
for developing PACG (Hu, 1989a). It is estimated that 3.5 million people in China have PACG 
and 28 million have narrow anterior chamber angles (Foster and Johnson, 2001).  
 
Malaysia is a heterogenous population with many races, of which Chinese and Malays 
predominate. According to the National Consensus 2010, Malays make up 61.9% of the 
population followed by Chinese (22.5%) and Indians (6.7%)(Department of Statistics, 2010). 
Interestingly, although PACG is often associated with Chinese ethnicity, in a retrospective 
study of chronic angle closure glaucoma in Malaysia, Taiwan, and Hong Kong found that the 
progression rate of PACG was higher in Malays when compared to Chinese (Liza-Sharmini et 
al., 2009). Another publication by Sharmini AT, et al, 2014 on Malay patients with PACG 
found that Malay PACG patients have the risk of progression up to 16-fold. A genome wide 
association study showed susceptibility loci associated with PACG, suggesting that genetic 
development of the eye in different races may be a contributory factor in the pathogenesis of 
PACG (Vithana et al., 2012). 
 
In this study, we will analyze the association of axial length (AL), anterior chamber depth 
(ACD) and anterior chamber angle (ACA) with progression of PACG. In addition, we will also 
determine the relationship between ethnicity and progression of PACG. By doing so, we hope 
to improve the monitoring and treatment of these patients. 
 
 
 
2.0 RATIONALE OF STUDY 
 
Risks factors for progression in glaucoma have been mostly obtained from studies on open 
angle glaucoma, and only scanty data available for progression in PACG. Crowded anterior 
segment is a known risk for developing PACG. However, the association of anterior segment 
biometry parameters with progression of PACG is still not well researched up to current date. 
Despite of the high prevalence of PACG in Chinese patients, but surprisingly Malay PACG 
patients tends to progress more rapidly than Chinese patients based on a retrospective study by 
Liza-Sharmini AT, et al, 2014 (Liza-Sharmini et al., 2014). Hence, this study to compare the 
anterior segment biometry parameters in Malay and Chinese PACG patients which will aid in 
understanding the role of anterior segment biometry parameters with progression of PACG. 
Identification of susceptible patient for progression will help in customization of treatment to 
prevent further glaucomatous damage.   
 
 
 
 
3.0 RESEARCH OBJECTIVE 
3.1 General Objective 
To evaluate anterior segment biometry in progress and non-progress PACG among Malay and 
Chinese patients. 
 
3.2 Specific Objectives 
1) To compare the mean anterior segment biometry parameters between Malay and Chinese 
PACG patients 
2) To compare the mean anterior segment biometry parameters with progression between 
Malay and Chinese patients 
3) To compare the mean anterior segment biometry parameters with non progression between 
Malay and Chinese patients 
  
4.0 RESEARCH QUESTION 
1. What is the differences in mean anterior segment biometry between Malay and Chinese 
PACG patients? 
2. What is the differences in mean anterior segment biometry with progression between Malay 
and Chinese PACG patients? 
3. What is the differences in mean anterior segment biometry with non-progression between 
Malay and Chinese PACG patients? 
 
 
 
 
5.0 RESEARCH HYPOTHESIS 
2. There is differences in mean anterior segment biometry between Malay and Chinese PACG 
patients. 
3. There is differences in mean anterior segment biometry with progression between Malays 
and Chinese PACG patients. 
4. There is differences in mean anterior segment biometry with non-progression between 
Malay and Chinese PACG patients. 
 
 
6.0 DEFINITION OF TERMS 
6.1 Primary angle closure glaucoma (PACG) 
PACG was classified as synechial or appositional. Primary (appositional) angle closure 
glaucoma was defined as raised IOP (>21 mm Hg) associated with non-visibility of the filtering 
trabecular meshwork for more than 180 degrees, with presence of peripheral anterior 
synechiae, glaucomatous disc, or field changes (Foster et al., 2002). 
 
6.2 Axial length (AL) 
Axial length (AL) is the distance from the posterior corneal surface to an interference peak 
corresponding to retinal pigment epithelium/Bruch's membrane (Hitzenberger, 1991). 
 
6.3 Anterior chamber depth (ACD) 
ACD is measured along posterior corneal surface to the anterior pole of the lens 
(Hitzenberger, 1991). 
 
 
 
 
6.5 Anterior chamber angle (ACA) 
The ACA is defined in degrees, in which the angle recess forms the apex and the two sides of  
the angle is formed by drawing the lines through the points defining the angle opening  
distance (AOD 500) (Huang).  
 
 
 
6.6 Visual Field (VF) tests 
Humphrey Field Analyzer set for the central 24-2 threshold test with size III white stimulus 
(Carl Zeiss Meditec, Inc, Dublin, California, USA).  A reliable HVF was based on fixation 
losses less than 20% with false-positives and - negatives less than 33%. Abnormal VF tests 
were defined as outside normal limits of glaucoma hemifield test or pattern standard deviation 
(PSD) outside the 95% normal limits. 
6.7 Progression of PACG 
Progression of PACG is based on the progression on the Hodapp,Parrish and Anderson’s 
Classification on progression on VF changes. This is a clinically useful method, and is currently 
the classication system most commonly used in clinical studies (Brusini and Johnson, 2007; 
Hodapp et al., 1993). 
 
VF progression is based on: 
1. New defects 
c) 3 or more non-edge points are depressed > 5dB or p < 5% 
d) 1 non-edge points are depressed >10dB 
2. Deeping defects 
c) 3 or more non-edge points are depressed >10dB 
d) May be different if contiguous 
3. Expanding scotoma 
b) 2 points within central 15 degree or 3 points outside central 15 degree are depressed 
>10dB or p>5%. 
 
 
 
 
 
7.0 METHODOLOGY 
7.1 Study design 
Cross-sectional study 
  
7.2 Study location 
Eye clinic, Hospital University Sains Malaysia (HUSM) 
 
7.3 Study duration 
May 2014 - June 2016 
 
7.4 Study reference population 
All Malay and Chinese PACG patients 
7.5 Source population 
All Malay and Chinese patients in eye clinics in HUSM. 
 
7.6 Sampling frame 
All Malay and Chinese PACG patients fulfill inclusion and exclusion criteria who attended 
eye clinic HUSM from May 2014 - June 2016. 
 
 
 
 
 
 
 
7.7 Inclusion and exclusion criteria 
Inclusion criteria  
1. Confirmed diagnosis of PACG with or without acute primary angle closure (APAC)  
2. At least 5 reliable reproducible visual fields are available for analysis 
3. At least 2 years of reliable and reproducible visual fields are available for analysis. 
4. Malay and Chinese ethnicity without any interracial marriages for 3 generations 
 
Exclusion criteria    
1. Patients with secondary angle closure such as neovascularization of the iris, uveitis, 
trauma, lens intumescence, or subluxation  
2. Patients with non glaucomatous optic neuropathy that would affect visual field 
progression. 
3. Patients with retinal diseases which would affect visual field progression 
4. Patients with history of panretinal photocoagulation laser therapy  
5. Patients with high refractive error with spherical equivalent less than -8 or greater than +4 
diopter. 
6. Patients with cataract of nuclear opalescence(NC) >2 , cortical(C) >2 and posterior 
subcapsular(P) >2 based on Lens Opacities Classification System III (LOCSIII) 
7. Patients who had any intraocular surgery that would affect the natural anatomy of anterior 
segment biometry 
8. Patients with severe corneal diseases which will preclude an adequate view of the anterior 
segment when performing AS-OCT examination 
 
 
 
7.8 Sample size calculation 
Objective 1 
1) To compare the mean anterior segment biometry parameters between Malay and 
Chinese PACG patients. (Fan et al., 2013)(Nai-wen Fan et al, 2013; Shah FO et 
al,2011; Guo yin et al, 2012) 
*Calculation was done based on power and sample size programme (PS programme) 
N =27+ (20% dropout)  =36  (for Malay and Chinese respectively)  
N= sample size 
Total Sample size = 72 (Malay =36 and Chinese =36) 
Objective 2 
2) To compare the mean anterior segment biometry parameters with progression between 
Malay and Chinese patients (Fan et al., 2013) Shah FO et al,2011; Guo yin et al, 2012) 
*Calculation was done based on power and sample size programme (PS programme) 
N =17+ (20% dropout)  =22  (for Malay and Chinese respectively)  
N= sample size 
Total Sample size = 44 (Malay =22 and Chinese =22) 
Objective 3 
3) To compare the mean anterior segment biometry parameters with non-progression 
between Malay and Chinese patients (Fan et al., 2013)Shah FO et al,2011; Guo yin et 
al, 2012) 
*Calculation was done based on power and sample size programme (PS programme) 
N =20+ (20% dropout) =24  (for Malay and Chinese respectively)  
N= sample size 
Total Sample size = 48 (Malay =24 and Chinese =24) 
 
7.9 Sampling method 
Simple random sampling of all PACG Malay and Chinese patients attending eye clinic 
HUSM. 
 
7.10 Research tools 
1. Snellen chart for distance (Reichert, NY, USA) 
2. Goldmann Applanation Tonometer 
3. Slit Lamp Biomicroscopy (Clement Clark International, UK) with 90D and 78D lenses 
(Volk, USA) 
4. IOL Master (Carl Zeiss Meditec, Inc) 
5. Anterior Segment Optical Coherence Topography (Spectralis Heidelberg, Germany) 
6. Humphrey fields analyzer  
 
7.11 Data collecting procedure 
The study will be conducted after obtaining approval from the Universiti Sains Malaysia 
Ethical Committee. All Malay and Chinese patients with PACG attending the ophthalmology 
clinic HUSM will be selected according to our inclusion and exclusion criteria. Series of visual 
field of the selected patients will be re-analysed by the primary investigator and glaucoma 
specialist to determine the progression of the disease. Only patient with 3 reliable and 
reproducible visual fields including the current visual field will be selected. If both eyes are 
eligible for recruitment, only right eye will be selected. Participation in this study is expected 
to last up to 2 days which includes two separate visits to eye clinic with each visit will take 
around 2 hours. During the first visit, patient will be informed and counselled by the primary 
investigator on the study’s purpose, procedures, patients’ selection criteria, risks and other 
components in details as mentioned in the patient information sheet as attached. After that, 
patients will be given time (customized to cater each patient) for consideration and discussion 
with family members if necessary. Only patients who are interested to participate in the study 
will be arranged for the second visit via phone call. During the second visit, consent will be 
taken if patients do not have any further enquiries. Subsequently, a thorough routine ocular 
examination will be conducted including slitlamp examination, gonioscopic evaluation and 
IOP measurement using Goldmann Applanation Tonometry (GAT) during the recruitment 
period. Refractive assessment will be carried out by a trained optometrist. Additional non-
invasive study examinations are Axial length measurement will be done using a noncontact 
partial coherence interferometer (IOL Master, Carl Zeiss, Germany) on selected eye by a 
trained optometrist. Anterior Segment-OCT (Cirrus, Carl Zeiss, Germany) measurements 
(Anterior chamber depth and anterior chamber angle) of the same eye will be performed by the 
same experienced operator without pupil dilation in the same room in standard illumination 
conditions. The best image is choose based on the operator best judgement at that point, with 
a focus on achieving an image with neither motion artifacts nor image artifacts due to the 
eyelids. The image which able is to provide the best visibility of the sclera spur both sclera 
spurs was selected and saved for analysis. In a darkened room (to allow pupil to dilate), topical 
phenylephrine 2.5% and tropicamide 1% will be instilled into the eyes three times prior to 
examination. Lens thickness is then measured with AS-OCT as it requires pupil dilatation. 
These additional non-invasive examinations sometimes will be carried out on certain PACG 
patients to ease and plan the management for these patients. All data will be collected and 
analyzed using SPSS Version 20.0. 
 
7.12  Statistical analysis 
All data will be entered and analyzed using SPSS version 20.0. For descriptive statistics, data 
will be presented by mean (sd) for numerical variables. Univariate analysis using independent 
t-test. P-value less than 0.05 were considered statistically significant. Mean values were 
reported with standard deviation (mean+ SD) 
 
7.13 Ethic consideration 
This study will be submitted to the Ethical Committee of USM. An information form will be 
given to all participants prior to data collection. Written consent will be obtained from the 
patients 
 
 
 
 
 
 
 
 
 
 
 
7.14 Flow Chart 
Malay
Malay and Chinese PACG Patients 
Humphrey Visual Field Analysis 
- At initial diagnosis 
- At the time recruitment
Progress  Patients Non Progress  Patients
Malay Chinese Chinese
Anterior  segment  biometry parameters examination   
(AL,ACD,LT,ACA )
Analysis 
  
7.15 Dummy tables  
 
Objective 1 
To compare the mean anterior segment biometry parameters between Malay and Chinese 
PACG patients. 
Anterior  
Segment 
Biometry 
Parameters
PACG patients  
Mean  (SD)
P value
Malay Chinese
AL (mm)
ACD (mm)
LT (mm)
ACD (mm)
 
 
 
Objective 2 
 
To compare the mean anterior segment biometry parameters with progression between Malay 
and Chinese patients. 
Anterior  
Segment 
Biometry 
Parameters
Progress PACG patients
Mean  (SD)
P value
Malay Chinese
AL (mm)
ACD (mm)
LT (mm)
ACD (mm)
 
Objective 3 
 
 To compare the mean anterior segment biometry  parameters with non progression between 
Malay and Chinese patients.  
 
8.0 BUDGET 
Not applicable 
 
 
9.0 GHANNT CHART 
Milestone
YEAR
2015 2016 2017
M A M J J A S O N D J F M A M J J A S O N D J F M A
Malay and 
chinese patients 
recruitment
HVF analysis
Anterior segment 
biometry 
examination
Data analysis
 
 
10.0 KEY MILESTONE 
 
1. Proposal preparation and ethical approval- By April 2015 
2. Data collection – By June 2016 
3. Data analysis- By December 2016 
4. Report writing and correction – By August 2017 
5. Submit final draft – By September 2017 
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thickness and anterior chamber angle-angle of space in between cornea and iris of the eye . Before 
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CONFIDENTIALITY 
 
Your medical information will be kept confidential by the study doctor and staff and will not be made 
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 Signature of Patient or Legal Representative    Date (dd/MM/yy) 
(Add time if applicable) 
 
 
 
Name of Individual  
Conducting Consent Discussion (Print or Type) 
 
 
 
 
Signature of Individual       Date (dd/MM/yy) 
Conducting Consent Discussion   
 
 
 
 
Name & Signature of Witness                Date (dd/MM/yy) 
 
 
 
Note:  i) All subject/patients who are involved in this study will not be covered by insurance. 
  
ATTACHMENT G 
 
 
Patient/ Subject Information and Consent Form 
(Signature Page) 
 
 
Research Title: Evaluation of anterior segment biometry parameters in 
progress and non-progress primary angle closure 
glaucoma among Malays and Chinese 
 
Researcher’s Name:  Dr Neoh Pei Fang (MPM No/; 50547) 
 
To become a part this study, you or your legal representative must sign this page. By signing this page, 
I am confirming the following: 
 
▪ I  have  r ead  a l l  o f  t he  in fo rma t io n  in  th i s  Pa t ien t  I n forma t io n  and  Consen t  
Fo rm inc lud ing  a ny  informa t io n  reg arding  the  r i sk  in  thi s  s tudy  and  I  
have  had  t ime  to  th ink  abo ut  i t .  
▪ Al l  o f  my q ues t io ns  have  b een  answered  to  my sa t i s fac t io n .  
▪ I  vo lun tar i ly  agree  to  b e  par t  o f  t h i s  r e sear ch  s tud y,  to  fo l lo w the  s tud y 
p roced ures ,  and  to  p ro vid e  necessa ry  in fo rma t io n  to  the  doc to r ,  nur se s ,  o r  
o ther  s t a f f  memb er s ,  a s  req ues ted .  
▪ I  may f r ee ly  choo se  to  s top  b e ing  a  p ar t  o f  t h is  s tud y a t  anyt ime .  
▪ I  have  r ece ived  a  co p y o f  th i s  P a t i en t  I n fo rma t io n  and  Co nsen t  Form to  
keep  for  myse l f .  
 
 
 
Patient Name (Print or type)      Patient Initials and Number 
 
 
 
Patient I.C No. (New)       Patient I.C No. (Old) 
 
 
  
Signature of patient or Legal Representative    Date (dd/MM/yy) 
(Add time if applicable) 
 
 
 
 
Name of Individual  
conducting Consent Discussion (Print or Type) 
 
 
 
 
Signature of Individual       Date (dd/MM/yy) 
Conducting Consent Discussion   
 
 
 
 
Name & Signature of Witness                Date (dd/MM/yy) 
 
 
Note:  i) All subject/patients who are involved in this study will not be covered by insurance. 
ii) Excess samples from this research will not be used for other reasons and will be destroyed with the consent 
from the Research Ethics Committee (Human), USM.  
ATTACHMENT P 
 
 
Patient’s Material Publication Consent Form 
Signature Page 
 
Research Title: Evaluation of anterior segment biometry parameters in 
progress and non-progress primary angle closure 
glaucoma among Malays and Chinese 
 
Researcher’s Name:  Dr Neoh Pei Fang (MPM No: 50547) 
 
 
To become a part this study, you or your legal representative must sign this page.  
 
By signing this page, I am confirming the following: 
 
▪ I  und er s to od  tha t  my name  wi l l  no t  app ea r  o n the  ma te r ia l s  p ub l i shed  and  
the re  has  been  e f for t s  t o  make  sure  tha t  t he  p r ivacy  o f  my name  i s  kep t  
co nf id en t ia l  a l tho ugh  the  co nf id en t i a l i t y  i s  no t  co mp le te ly  gua ran teed  d ue  
to  unexp ec ted  c i rcumst ances .  
 
▪ I  have read the materials or general  description of what the material contains and 
reviewed all photographs and figures in which I am included that could be 
published.  
 
▪ I  have been offered the opportunity to read the manuscript  and to see all  materials 
in which I am included, but have waived my right to do so.  
 
▪ Al l  the  p ubl i shed  ma ter i a l s  wi l l  b e  shared  amo ng  the  med ica l  p r ac t i t ione r s ,  
sc i en t i s t s  and  jo urna l i s t  wo r ld  wid e .  
 
▪ T he  ma ter ia l s  wi l l  a l so  b e  used  in  loca l  p ub l ica t io ns ,  boo k  p ubl i ca t io ns  and  
accessed  b y man y lo ca l  and  in te rna t io na l  d oc tor s  wo r ld  wid e .  
 
▪ I  her eb y agree  and  a l lo w the  ma te r ia l s  to  b e  used  in  o the r  p ub l i ca t io ns  
r eq u i r ed  b y o the r  p ub l ishe r s  wi th  these  co nd i t io ns :  
▪ T he  ma te r i a l s  wi l l  no t  b e  used  a s  ad ve r t i sement  p urpo ses  nor  a s  packaging  
ma te r i a l s .  
 
▪ T he  ma ter i a l s  wi l l  no t  be  used  o u t  o f  co n tex  –  i . e . :  Samp le  p i c tu r e s  wi l l  no t  
b e  used  in  an  ar t ic l e  wh ich  i s  unre l a ted  sub j ec t  to  the  p ic tu re .  
 
 
 
Patient Name (Print or type)     Patient Initials or Number 
 
 
 
 
Patient I.C No.   Patient’s  Signature  Date (dd/MM/yy) 
 
 
 
 
 
Name and Signature of Individual     Date (dd/MM/yy) 
Conducting Consent Discussion  
 
Note:  i) All subject/patients who are involved in this study will not be covered by insurance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CONSENT FORM (MALAY) 
 
MAKLUMAT KAJIAN 
 
Tajuk Kajian:  “Evaluation of anterior segment biometry parameters in progress and 
non-progress primary angle closure glaucoma among Malays and 
Chinese” 
 
Nama Penyelidik:  Dr Neoh Pei Fang 
 
No. Pendaftaran MMC : MPM 50547 
 
Nama Penyelia Penyelia : Prof Dr Liza Sharmini Ahmad Tajudin 
 
PENGENALAN 
 
Anda dipelawa untuk menyertai satu kajian penyelidikan secara sukarela yang melibatkan pemeriksaan 
dan penilaian "anterior segment biometry parameters". Antara "anterior segment biometry parameters" 
yang akan dinilai adalah kepanjangan bola mata -"axial length", kedalaman ruang depan mata - 
"anterior chamber depth", ketebalan kanta-"lens thickness" and sudut ruang depan mata-" anterior 
chamber angle". Sebelum anda bersetuju untuk menyertai kajian penyelidikan ini, adalah penting anda 
membaca dan memahami borang ini. Sekiranya anda menyertai kajian ini, anda akan menerima satu 
salinan borang ini untuk disimpan sebagai rekod anda. 
 
Penyertaan anda di dalam kajian ini dijangka mengambil masa dua hari termasuk dua lawatan klinik  
pada hari yang berlainan yang mengambil masa lebih kurang dua jam. Seramai 80 pesakit akan 
menyertai kajian ini. 
 
TUJUAN KAJIAN  
 
Kajian ini bertujuan adalah untuk menentukan sama ada, terdapat perbezaan "anterior segment 
biometry parameters" antara pesakit Melayu dan pesakit Cina yang menghidapi "progress" dan "non- 
progress" "primary angle closure glaucoma"  
 
Terdapat kemungkinan maklumat yang dikumpulkan semasa kajian ini akan dianalisa oleh pihak 
penyelidik pada masa depan untuk menilai "anterior segment biometry parameters" untuk kegunaan 
lain yang mungkin atau untuk tujuan perubatan atau saintifik lain yang selain dari yang kini 
dicadangkan. 
 
 
 
 
KELAYAKAN PENYERTAAN 
 
Doktor yang bertanggungjawab dalam kajian ini atau salah seorang kakitangan kajian telah 
membincangkan kelayakan untuk menyertai kajian ini dengan anda. Adalah penting anda berterus 
terang dengan doktor dan kakitangan tersebut tentang sejarah kesihatan anda. Anda tidak seharusnya 
menyertai kajian ini sekiranya anda tidak memenuhi semua syarat kelayakan. 
 
Beberapa keperluan untuk menyertai kajian ini adalah – 
 Anda mengidap "primary angle closure glaucoma"  
 Anda mempunyai sekurang-kurangnya 5 atau lebih "visual field" yang boleh dipercayai. 
 Anda mesti mempunyai "visual field" yang boleh dipercayai dalam masa sekurang-
kurangnya 2 tahun 
 
Anda tidak boleh menyertai kajian ini sekiranya – 
 Anda menghidap "secondary angle closure glaucoma" 
 Anda menghidap "non-glaucomatous optic neuropathy" yang akan menjejaskan "visual 
field" 
 Anda menghidap penyakit retina yang akan menjejaskan "visual field" 
 Anda pernah menjalani prosedure laser terapi "pan retinal photocoagulation" 
 Anda mempunyai ralat refraksi dengan "spherical equivalent" yang tidak melebihi +4 diopter 
atau kurang daripada -8 diopter. 
 Anda mempunyai katarak yang melebihi grade yang ditetapkan 
 Anda pernah menjalani pembedahan mata yang akan menjejaskan anatomi mata 
 Anda mempunyai masalah kornea yang akan menghindari daripada pemerhatian dan 
penilaian "anterior segment ". 
 
 
PROSEDUR-PROSEDUR KAJIAN 
 
Pada lawatan pertama anda, anda akan diberitahu dan dikaunsel oleh penyelidik tentang tujuan 
penyelidikan, prosedur yang akan dijalankan ke atas anda, syarat pemilihan calon penyelidikan, risiko  
dan lain-lain hal yang berkenaan seperti di bawah. Lepas itu, anda akan diberi masa untuk membuat 
pertimbangan dan perbincangan dengan ahli keluarga jika perlu. Masa yang diperuntukkan tertakluk 
kepada calon penyelidikan masing-masing. Sekiranya anda setuju menyertai kajian, anda perlu 
melawat ke klinik mata pada kali kedua untuk menandatangani borang keizinan penyelidikan dan anda 
akan menjalani pemeriksaan mata yang terperinci yang termasuk pemeriksaan "slitlamp", "gonioscopy" 
sudut pemeriksaan dan pengambilan bacaan tekanan mata.  Anda Akan diminta memberi maklumat 
tentang sejarah perubatan anda, termasuk bila "primary angle closure glaucoma" anda didiagnosa.  
Pemeriksaan "anterior segment biometry parameters" merupakan pemeriksaan yang tidak invasif 
tambahan untuk tujuan penyelidikan yang akan dilakukan. Pemeriksaan ini kadang-kala akan 
dijalankan ke atas sesetengah pesakit "primary angle closure glaucoma" untuk tujuan rancangan 
rawatan. "Kepanjangan bola mata- Axial length" akan diukur dengan menggunakan mesin " non- 
contact partial coherence inferometer (IOL Master , Zeiss, Germany) atas mata yang dipilih oleh 
optometrist yang terlatih. Ukuran "Kedalaman ruang di antara kornea dan iris-anterior chamber depth" 
dan "sudut ruang di antara kornea dan iris-anterior chamber angle" atas mata yang sama akan dibuat 
oleh operator yang berpengalaman tanpa pengembangan anak mata dengan mesin AS-OCT dalam 
bilik yang pencahayaan yang standard. Imej yang paling jelas and terbaik akan dipilih mengikut 
pengalaman operator. Selepas itu, dalam bilik yang gelap untuk membenarkan pengembangan anak 
mata, ubat titis mata "phenyephrine 2.5% dan tropicamide 1% akan dititis ke dalam mata yang akan 
diperiksa. "Ketebalan kanta- Lens thickness" akan diukur dengan mesin AS-OCT. 
 
RISIKO 
 
Ini merupakan satu pemeriksaan mata yang tidak invasif dan biasa dijalankan di Klinik mata. Akan 
tetapi, sekiranya anda menyertai kajian ini, anda mungkin mengalami risiko seperti alahan kepada ubat 
titis mata untuk pengembangan anak mata seperti megalami kemerahan, bengkak, atau gatal pada 
mata atau muka. Tanda-tanda ini biasanya hilang dalam masa beberapa jam hingga beberapa hari. 
Tetapi, ubat titis mata yang akan dip akan merupakan ubat titis mata yang digunakan dalam 
pemeriksaan mata biasa dalam klinik mata. 
Jika apa-apa maklumat penting yang baru dijumpai semasa kajian ini yang mungkin mengubah 
persetujuan anda untuk terus menyertai kajian ini, anda akan diberitahu secepat mungkin. 
 
 
MELAPORKAN PENGALAMAN KESIHATAN 
 
Jika anda mengalami apa-apa kecederaan, kesan buruk, atau apa-apa pengalaman kesihatan yang 
luarbiasa semasa kajian ini, pastikan anda memberitahu jururawat atau Dr. Neoh Pei Fang [No. 
Pendaftaran Penuh Majlis Perubatan Malaysia: 50547] di talian 097676362 secepat mungkin. Anda 
boleh membuat panggilan pada bila-bila masa, siang atau malam, untuk melaporkan pengalaman 
sedemikian. 
 
 
PENYERTAAN DALAM KAJIAN 
 
Penyertaan anda dalam kajian ini adalah secara sukarela. Anda berhak menolak untuk menyertai kajian 
ini atau anda boleh menamatkan penyertaan anda pada bila-bila masa, tanpa sebarang hukuman atau 
kehilangan manfaat yang sepatutnya anda perolehi. 
Penyertaan anda juga mungkin boleh diberhentikan oleh doktor yang terlibat dalam kajian ini tanpa 
persetujuan anda. Sekiranya anda berhenti menyertai kajin ini, doktor yang terlibat di dalam kajian ini 
atau salah seorang kakitangan akan berbincang dengan anda mengenai apa-apa isu perubatan 
berkenaan dengan pemberhentian penyertaan anda.. 
 MANFAAT YANG MUNGKIN [Manfaat terhadap Individu, Masyarakat, Universiti] 
Prosedur kajian ini akan diberikan kepada anda tanpa kos.  Anda mungkin menerima maklumat tentang 
kesihatan anda daripada pemeriksaan fizikal dan ujian makmal yang dilakukan dalam kajian ini. Hasil 
atau maklumat kajian ini diharapkan, dapat memberi manfaat kepada pesakit-pesakit pada masa 
hadapan. Anda tidak akan menerima sebarang pampasan kerana menyertai kajian ini. Namun 
sebarang keperluan perjalanan berkaitan dengan penyertaan ini akan diberi. 
 
PERSOALAN 
 
Sekiranya anda mempunyai sebarang soalan mengenai prosedur kajian ini atau hak-hak anda, sila 
hubungi; 
Penyelidik: 
DR NEOH PEI FANG, MPM 50547 
JABATAN OFTALMOLOGI 
HOSPITAL UNIVERSITI SAINS MALAYSIA 
097676362 
Email: pf 
neoh@hotmail.com 
 
Peyelia penyelidik: 
PROF DR LIZA SHARMINI AHMAD TAJUDIN 
JABATAN OFTALMOLOGI 
HOSPITAL UNIVERSITI SAINS MALAYSIA 
097676362 
Email: liza@usm.my 
 
 
 
 
 
Sekiranya anda mempunyai sebarang soalan berkaitan kelulusan Etika atau sebarang pertanyaan dan 
masalah berkaitan kajian ini, sila hubungi; 
 
   En. Mohd Bazlan Hafidz Mukrim 
Setiausaha Jawatankuasa Etika Penyelidikan (Manusia) USM 
Pusat Inisiatif Penyelidikan -Sains Klinikal & Kesihatan 
USM Kampus Kesihatan. 
No. Tel: 09-767 2354 / 09-767 2362 
Email: bazlan@usm.my/jepem@usm.my 
 
 
KERAHSIAAN 
 
Maklumat perubatan anda akan dirahsiakan oleh doktor dan kakitangan kajian. Ianya tidak akan 
dedahkan secara umum melainkan jika ia dikehendaki oleh undang-undang. 
 
Data yang diperolehi dari kajian yang tidak mengenalpasti anda secara perseorangan mungkin akan 
diterbitkan untuk tujuan memberi pengetahuan baru. 
 
Rekod perubatan anda yang asal mungkin akan dilihat oleh pihak penyelidik, Lembaga Etika kajian ini 
dan pihak berkuasa regulatori untuk tujuan mengesahkan prosedur dan/atau data kajian klinikal.  
Maklumat perubatan anda mungkin akan disimpan dalam komputer dan diproses dengannya. 
 
Dengan menandatangani borang persetujuan ini, anda membenarkan penelitian rekod, penyimpanan 
maklumat dan pemindahan data seperti yang dihuraikan di atas. 
 
 
TANDATANGAN 
Untuk dimasukkan ke dalam kajian ini, anda atau wakil sah anda mesti menandatangani serta 
mencatatkan tarikh halaman tandatangan. 
 
 
LAMPIRAN S 
 
 
Borang Keizinan Pesakit/ Subjek 
(Halaman Tandatangan) 
 
Tajuk Kajian:  “Evaluation of anterior segment biometry parameters in progress and non-
progress primary angle closure glaucoma among Malays and Chinese” 
 
Nama Penyelidik:  Dr Neoh Pei Fang (MPM 50547) 
    
 
Untuk menyertai kajian ini, anda atau wakil sah anda mesti menandatangani mukasurat ini. Dengan 
menandatangani mukasurat ini, saya mengesahkan yang berikut: 
 
▪  Sa ya  te lah  m em baca  sem ua m ak lum at  da lam  Borang Mak lumat  dan  
Ke iz inan  Pesak i t  in i  termasuk apa-apa maklumat  berkai tan  r is iko  
yang ada dalam kaj ian  dan sa ya  te lah  pun d iber i  m asa yang m encukup i  
un tuk  m em per t im bangkan  m ak lum at  te rsebu t .  
▪  Sem ua soa lan-soa lan  saya te lah  d i jawab  dengan m em uaskan.  
▪  Sa ya,  secara  sukare la ,  berse tu ju  m enyer ta i  ka j ian  pen ye l id ikan  in i ,  
m em atuh i  sega la  p rosedur  ka j ian  dan  m em ber i  m ak lum at  yang  
d iper lukan  kepada  dok tor ,  para  ju rurawat  dan juga  kak i tangan  la in  yang  
berka i tan  apab i la  d im in ta .  
▪  Sa ya  bo leh  m enam atkan  penyer taan  sa ya  da lam  ka j ian  in i  pada  b i la -
b i l a  m asa.  
▪  Sa ya  te lah  pun  m ener im a satu  sa l inan  Borang Mak lum at  dan  Ke iz inan  
Pesak i t  un tuk  s im panan per ibad i  saya .  
 
 
 
 
Nama Pesakit (Dicetak atau Ditaip)    Nama Singkatan & No. Pesakit 
 
 
 
No. Kad Pengenalan Pesakit (Baru)    No. K/P (Lama) 
 
 
 
Tandatangan Pesakit atau Wakil Sah    Tarikh (dd/MM/yy) 
(Masa jika perlu) 
 
 
Nama & Tandatangan  Individu yang Mengendalikan    Tarikh (dd/MM/yy) 
Perbincangan Keizinan (Dicetak atau Ditaip) 
 
 
 
Nama Saksi dan Tandatangan     Tarikh (dd/MM/yy) 
 
 
Nota: i) Semua subjek/pesakit yang mengambil bahagian dalam projek penyelidikan ini tidak dilindungi insuran. 
LAMPIRAN G 
 
Borang Keizinan Pesakit/ Subjek untuk Sampel Genetik 
(Halaman Tandatangan) 
 
Tajuk Kajian: “Evaluation of anterior segment biometry parameters in progress and 
non-progress primary angle closure glaucoma among Malays and 
Chinese” 
 
Nama Penyelidik:  Dr Neoh Pei Fang (MPM 50547) 
 
Untuk menyertai kajian ini, anda atau wakil sah anda mesti menandatangani mukasurat ini. Dengan 
menandatangani mukasurat ini, saya mengesahkan yang berikut: 
 
▪  Sa ya  te lah  m em baca  sem ua m ak lum at  da lam  Borang Mak lumat  dan  
Ke iz inan  Pesak i t  in i  termasuk apa-apa maklumat  berkai tan  r is iko  
yang ada dalam kaj ian  dan sa ya  te lah  pun d iber i  m asa yang m encukup i  
un tuk  m em per t im bangkan  m ak lum at  te rsebu t .  
▪  Sem ua soa lan-soa lan  saya  te lah  d i jawab  dengan m em uaskan.  
▪  Sa ya,  secara  sukare la ,  berse tu ju  m enyer ta i  ka j ian  pen ye l id ikan  in i ,  
m em atuh i  sega la  p rosedur  ka j ian  dan  m em ber i  m ak lum at  yang  
d iper lukan  kepada  dok tor ,  para  ju rurawat  dan juga  kak i tangan  la in  yang  
berka i tan  apab i la  d im in ta .  
▪  Sa ya  bo leh  m enam atkan  penyer taan  sa ya  da lam  ka j ian  in i  pada  b i la -
b i l a  m asa.  
▪  Sa ya  te lah  pun  m ener im a satu  sa l inan  Borang Mak lum at  dan  Ke iz inan  
Pesak i t  un tuk  s im panan per ibad i  saya .  
 
 
 
Nama Pesakit (Dicetak atau Ditaip)    Nama Singkatan & No. Pesakit 
 
 
 
No. Kad Pengenalan Pesakit (Baru)    No. K/P (Lama) 
 
 
 
Tandatangan Pesakit atau Wakil Sah    Tarikh (dd/MM/yy)    
        Masa (jika perlu) 
 
 
Nama & Tandatangan  Individu yang Mengendalikan    Tarikh (dd/MM/yy) 
Perbincangan Keizinan (Dicetak atau Ditaip) 
 
 
 
Nama Saksi dan Tandatangan     Tarikh (dd/MM/yy) 
 
 
Nota: i) Lebihan sampel kajian ini akan dilupuskan dan tidak akan digunakan untuk tujuan lain kecuali setelah mendapat  
  kebenaran daripada Jawatankuasa Etika Penyelidikan (Manusia), USM. 
 ii) Semua subjek/pesakit yang mengambil bahagian dalam projek penyelidikan ini tidak dilindungi insuran. 
LAMPIRAN P 
 
Borang Keizinan bagi Penerbitan Bahan yang berkaitan dengan Pesakit/ 
Subjek 
(Halaman Tandatangan) 
 
Tajuk Kajian: “Evaluation of anterior segment biometry parameters in progress and 
non-progress primary angle closure glaucoma among Malays and 
Chinese” 
 
Nama Penyelidik:  Dr Neoh Pei Fang (MPM 50547) 
 
 
Untuk menyertai kajian ini, anda atau wakil sah anda mesti menandatangani mukasurat ini.  
 
Dengan menandatangani mukasurat ini, saya memahami yang berikut: 
▪  Bahan yang akan  d i t e rb i tkan  tanpa d i lam pi rkan  dengan nam a saya dan 
se t iap  percubaan  yang akan d ibuat  un tuk  m em ast ikan  ke tanpanam aan  
saya.  Sa ya  m em aham i ,  wa laubaga im anapun,  ke tanpanam aan  yang  
sem purna  t idak  dapat  d i j am in .  Kem ungk inan  ses iapa  yang m enjaga  saya  
d i  hosp i ta l  a tau  saudara  dapat  m engena l i  saya.  
▪  Bahan yang  akan d i te rb i tkan  da lam  penerb i tan  
m ingguan/bu lanan/dw ibu lanan/suku  tahunan/dwi  tahunan m erupakan  
sa tu  pen yebaran  yang luas  dan te rsebar  ke  se luruh  dun ia .  Kebanyakan  
penerb i tan  in i  akan te rsebar  kepada dok tor -dok tor  dan  juga  bukan  
dok tor  te rm asuk  ah l i  sa ins  dan ah l i  j u rna l .  
▪  Bahan te rsebut  j uga  akan d i lam pi rkan  pada lam an web ju rna l  d i  se lu ruh  
dun ia .  Sesetengah  lam an web in i  bebas  d ikun jung i  o leh  sem ua orang.  
▪  Bahan te rsebut  j uga  akan d igunakan  sebaga i  penerb i tan  tem patan  dan  
d isam paikan  o leh  ramai  dok tor  dan ah l i  sa ins  d i  se luruh  dun ia .  
▪  Bahan te rsebut  j uga  akan d igunakan  sebaga i  penerb i tan  buku  o leh  
penerb i t  j u rna l .  
▪  Bahan te rsebu t  t idak  akan d igunakan  untuk  peng ik lanan  a taupun  bahan  
untuk  m em bungkus .  
 
Sa ya  juga  m em ber i  ke iz inan  bahawa bahan te rsebut  bo leh  d igunakan  sebaga i  
penerb i tan  la in  yang d im in ta  o leh  penerb i t  dengan k r i te r ia  ber iku t :  
▪  Bahan  te rsebu t  t idak  akan d igunakan  untuk  peng ik lanan  a tau  bahan  
untuk  m em bungkus .  
▪  Bahan te rsebut  t idak  akan d igunakan  d i  luar  konteks  –  contohn ya:  
Gam bar  t idak  akan d igunakan  untuk  m enggam barkan  sesuatu  ar t ike l  
yang t idak  berka i tan  dengan sub jek  da lam  fo to  te rsebut .  
 
 
Nama Pesakit (Dicetak atau Ditaip)    Nama Singkatan atau No. Pesakit 
 
 
No. Kad Pengenalan Pesakit  T/tangan Pesakit   Tarikh (dd/MM/yy) 
 
 
Nama & Tandatangan  Individu yang Mengendalikan    Tarikh (dd/MM/yy) 
Perbincangan Keizinan (Dicetak atau Ditaip) 
 
Nota: i) Semua subjek/pesakit yang mengambil bahagian dalam projek penyelidikan ini tidak dilindungi insuran. 
 
 
 
5.1.2 Case record form (CRF) 
 
CASE RECORD FORM 
Demographic  
 
Name  : 
IC Number :  
Age  : 
Sex  : M / F 
Race  :  
* any family history of interracial marriage: Y/N 
 
Social economic status 
 
Occupation  : 
Educational level : 
 
Clinical data 
 
History taking 
1. Date of diagnosis : 
2. Other ocular disorders: 
3. History of ocular surgery :  Yes/No,   
  if yes, please stated the type of surgery done: __________________ 
4. History of ocular trauma : Yes/No,   
 if yes, please stated the type of injury: __________________ 
 
 
 
 
 
 
 
 
 
 
Physical examination 
 
1. Best corrected vision acuity:  RE    LE 
2. Refractive status: 
RE 
LE 
 
 Near vision 
3. Cornea status : RE clear / Hazy/ decompensated LE clear / Hazy/ decompensated 
4. IOP at every visit :       
 
 
 
 
 
5.  Lens status          : Phakic / pseudophakic eye 
 
*if phakic eye, please stated the cataract grading of patient’s lens according to LOCSIII if 
applicable. 
 
RE         NS  LE NS 
              CC    CC 
              PSCC   PSCC 
 
6. Fundus examination : 
 
RE    LE 
 
 
Investigations 
 
6. Numbers of reliable HVF: 
 
 
Anterior segment biometry parameters 
 
Axial length (AL) : 
Anterior chamber depth (ACD) : 
Lens thickness (LT) : 
Anterior chamber angle (ACA) : 
 
RE LE 
  
  
  
5.2 Ethical approval letter and renewal of ethical approval letter by JEPeM, USM 
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',·I 
IJawatanlwasa Et ika Penyelidiknn :\1anus ia USM (JEPt'l\1) 
!Hu ma n Research Eth ics Conuni u~e US M ( IIR EC) 
9" November 2015 
Dr. Neoh Pel Fang 
Department of Ophthalmology 
School of Medical Sciences 
Universi ti Sa ins M alaysia 
16150 Kubang Kerian, Kelantan. 
JEPeM Code : USM/JEPeM/15060236 
1 Universlll Sains Malaysia 
f 1\cnnpu!i J\e!>ih~r~ ;~·. 
I 
){,il :",() tiuhan~ Ken;m, 
t\d an1;1n. ;\t;tl)lyt.ia. 
T: (iO~I ~ ~ fi7 ~()()U ,(,1mb. q:J,i l h!:W':! 
I 
f': GOfl - ':'(l':· '.!.'l.i I 
£: j('l'lt'tr.~usm.my 
www.j~·rl'm.kk.usm.my 
Protocol ntle : Evaluation of Anterior Segment Biometry Parameters in Progress and Non 
Progress Primary Angle Closure Glaucoma among Malays and Chinese. 
Dear Dr., 
We wish to inform you that your study protocol has been reviewed and is hereby granted approval 
for implementation by the Jawatankuasa Etika Penyelidikan Manusia Universiti Sains Malaysia 
(JEPeM·USM). Your study has been assigned study protocol code USM/JEPeM/15060236, which 
should be used for all communication to the JEPeM·USM related to this study. This ethica l clearance 
is valid from November 2015 until October 2016. 
The following documents have been approved for use in the study. 
1. Research Proposal 
In addition to the abovementioned documents, the following technica l document was included in 
the review on which this approval was based: 
1. Patient Information Sheet and Consent Form (English version) 
2. Patient Information Sheet and Consent Form {Malay version) 
3. Data Collection Sheet 
Attached document is the list of members of JEPeM-USM present during the full board meeting 
reviewing your protocol. · 
While the study is in progress, we request you to submit to us the following documents: 
1. Application for renewal of ethical approval 60 days before the expiration date of this 
approval through submission of JEPeM·USM fORM 3(8) 2014: Conti~ulng Review 
Application Form. Subsequently this need to be done yearly as long as the research goes on. 
2. Anyc~anges In the protocol, espemliy those that may adversely affect the safety of the 
partiC~pants dunng the conduct of the t rial including changes in personnel, must be 
subml.tt~d or reported using JEPeM·USM FORM 3(A) 2014: Study Protocol Amendment 
Submtsston Form. 
3. Revisions in the informed consent form using the JEPeM-USM FORM 3(A) 2014: Study 
Protocol Amendment Submission Form. 
4. Reports of adverse events including from other study sites (national, international) using the 
IEPeM·USM FORM 3(G) 2014: Adverse Events Report 5 N . · 
· OtiCe of early termination of the study and reasons for such using JEPeM·USM FORM 3(E) 2014. . 
6. Any event which may have ethical signi ficance. 
7. Any information which is needed by the JEPeM·USM t d · · 8 N 1· f · f . o 9. ongo1ng rev1ew. 
. o •ce o t ime o completion of the study using JEPeM·USM FORM 3(C) 2014 f' I . 
Form. . : ona Report 
  
 
 
 
Please note that forms may be downloaded from the JEPeM-USM website: www-jepem.kk.usm.mv 
Jawatankuasa Etika Penyelidikan (Manusia), JEPeM-USM is in compliance with the Declaration of 
Helsinki, International Conference on Harmonization (ICH) Guidelines, Good Clinical Practice (GCP) 
Standards, Council for International Organizations of Medical Sciences (CIOMS) Guidelines, World 
Health Organization (WHO) Standards and Operational Guidance for Ethics Review of Health-Related 
Research and Surveying and Evaluating Ethical Review Practices, EC/IRB Standard Operating 
Procedures (SOPs), and Local Regulations and Standards in Ethical Review. 
Thank you. 
"ENSURING A SUSTAINABLE TOMORROW" 
~----~~~-----------------­
PROF. DR. MOHO SHUJgU!GTHMAN 
Deputy Chairperson 
Jawatankuasa Etika Peo'yelidikan (Manusia) JEPeM 
Universiti Sa ins Malaysia 
<App(OV3l><Dr. Neoh Pei Fang><USM/JEPeM/lS060n6 
Pogez orz 
 
 
 
Jawatankuau Etika Penyelidikan Manuaia USM J ll u r11~11 l< •·••·udo Et h" • (",, , ,,,llt<·•· l 'S.\ 1 I II HE~·,EPeM) 
3d" November 2016 
P:' .. r ,.; 
Or. Neoh Pet Fane 
Department of Ophttlllmoloey 
School of Medical Sclenus 
UniversltJ Sains Malaysia 
16150 Kubans Kerlan, KelanUn. 
JEPeM USM Code: USM/JEPeM/15060236 
...._.,.,SliM.._... 
1\wnfJu• liniluua. 
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Study Protocol Title: Evaluation of Anterior Sepnent Biometry Parameters In Procr- and Non 
ProJr.., Prtmary Anile Closure Glaucomalmof1l Malaya and Chinese. 
Dear Dr: 
We w ish to inform you that the Jawatankuasa Etika Penyelidikan Manusla, Universiti Sains Malaysia 
(JEPeM·USM) acknowledged receipt of Continuing Review Application dated 25111 October 2016. 
Upon review of JEPeM·USM Form 3(8) 2015: Continuing Review Application Form, the committee' s 
decision for the EXTENSION OF APPROVAL IS APPROVED (start from t• November 2017 till 31• 
October 2017). The report is noted and has been included in the protocol file. 
Thank you for your continuing compliance with the requirements of the JEPeM-USM. 
"ENSIJRING A SIJSTAINABLE TOMORROW' 
Very truly yours, 
(~AN ROSTENBERGHE) 
Chairperson 
Jawatankuasa Etika Penyelidikan (Manusla), JEPeM 
Unlversiti Salns Malaysia 
u: Secretary 
Jawatankuasa Etika Penyelidikan (Manusia), JEPeM 
Universlti Sains Malaysia 
